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Abstract
The preimplantation period of development represents the highest interval of embryonic
loss throughout pregnancy. It is therefore imperative that we elucidate the mechanisms
involved in regulating preimplantation embryonic responses to stress and that govern
development. The MAPK pathways are involved in both responding to environmental
stress and regulation of development throughout embryogenesis, and are therefore good
candidates to study the mechanisms involved in preimplantation embryonic adaptation to
stress and development. The preimplantation embryo culminates in the development of a
fluid filled structure called the blastocyst. It is at this stage the first differentiation events
occur and the trophectoderm (TE), which will go on to form the embryonic portion of the
placenta, develops. The p38 MAPK is required for embryo development to proceed
beyond the 8-16 cell stage as well to play an adaptive role in regulating embryonic
response to culture stress. My hypothesis is that the MAPK pathways regulate expression
of TE associated proteins and apoptosis in response to culture stress and may regulate
expression of TE associated proteins by affecting SNAI1 and SNAI2 expression or
localization during blastocyst formation. I have shown that p38 MAPK regulates Aqp3
and Aqp9 expression in response to hyperosmotic stress in the blastocyst. I have also
demonstrated that p38 MAPK is required for blastocyst expansion and hatching and
regulates tight junction permeability and TJP1 localization during blastocyst formation.
The p38 MAPK pathway also affects Aqp3 mRNA expression and protein detection. The
p38 MAPK does not regulate apoptosis, however, the JNK/SAPK pathway does. I have
demonstrated that two transcription factors, Snai1 and Snai2, which are downstream
targets of the p38 MAPK pathway, are present throughout preimplantation development.
In other cell types, SNAI1 and SNAI2 regulate many genes involved in blastocyst
formation. I have shown that in the preimplantation embryo, SNAI1 and SNAI2 have a
unique asymmetric distribution pattern from the 2-cell to 8-cell stage, and are then
segregated to the TE of the blastocyst. These results suggest that SNAI1 and SNAI2 may
be involved in TE differentiation or regulation. Taken together, this data reveal the
contributions of p38 MAPK to the regulation of preimplantation development.

Key words:

Blastocyst, Culture, Stress, Development, p38 MAPK, JNK/SAPK,
AQP3, AQP9, Trophectoderm, SNAI1, SNAI2
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CHAPTER ONE
LITERATURE REVIEW AND INTRODUCTION
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1.1 Overview
Preimplantation development is defined as the period extending from fertilization to
attachment and implantation to the uterine wall, and is unique to mammals (Watson,
1992; Watson et al., 1992; Watson et al., 1999; Watson & Barcroft, 2001; Yamanaka et
al., 2006; Rossant, 2007; Bell et al., 2008). During preimplantation development, the
embryo undergoes several molecular and morphological events, including compaction,
and blastocyst formation and cavitation, as a prelude to implantation. Compaction is
characterized by the establishment of cell-cell junctions that foster a dramatic change in
the appearance of the embryo from a small group of circular cells or blastomeres to a
tightly grouped mass of blastomeres lacking individual cell outlines (Fleming et al., 1991;
Fleming, et al., 2000; Ohsugi et al., 1996). The blastocyst is a fluid filled structure
composed of two distinct cell types, the undifferentiated and apolar inner cell mass (ICM)
that will give rise to the embryo proper and the extraembryonic ectoderm, and the
trophectoderm (TE), a polarized epithelium that will contribute to the embryonic portion
of the placenta (Hansis et al., 2000; MacPhee et al., 2000; Pampfer, 2000; Sheth et al.,
2000; Fleming et al., 2001; Leunda-Casi et al., 2001; Watson & Barcroft, 2001; Kidder,
2002; Barcroft et al., 2003; Ghassemifar et al., 2003; Kim et al., 2004; Kunath et al.,
2004; Watson et al., 2004; Niwa et al., 2005; Ralston & Rossant, 2005; Strumpf et al.,
2005; Nagy & Vintersten, 2006; Oda et al., 2006; Yamanaka et al., 2006; Rossant, 2007).
The studies composing my thesis focus on defining the molecular and signaling events
that control the developmental program that results in TE differentiation and
subsequently, blastocyst formation.

As assisted reproductive technologies (ARTs)

expose the preimplantation embryo to exogenous stress, my studies also investigate
signaling events that contribute to the preimplantation embryo’s ability to adapt to an in
vitro environment (Bell et al., 2008). The outcomes of my studies reveal new paradigms
for understanding how critical gene families that are implicated in TE differentiation and
blastocyst formation are regulated and also provide insights into how exposure to culture
environments affects these developmental programs.
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1.2 Assisted Reproduction
ARTs seek to aid couples who may be suffering from subfertility/infertility. Elucidating
how these technologies may be affecting embryonic health is imperative (Seamark &
Robinson, 1995; Rizos et al., 2002; Gardner et al., 2005; Wells et al., 2005; Giritharan et
al., 2007). In 2008 alone, over 61,000 births (>1%) in the United States were conceived
through ART. However over the past few years, research has demonstrated that singleton
children born through ART have increased adverse outcomes compared to singleton
babies born from naturally conceived pregnancies. These adverse outcomes include
preterm birth, low birth weight, or very low birth weight (reviewed in Kalra & Barnhart,
2011; Schieve et al., 2002; Bower & Hansen, 2005; Gardner et al., 2005; Wells et al.,
2005)
The majority of adverse ART outcomes are primarily due to the complications associated
with multiple births (Kalra & Barnhart, 2011). This is due to the common practice of
transferring multiple embryos into the uterus to increase the opportunity for implantation
and pregnancy with a 14x increase of twins and a 54x increase of triplets in ART
pregnancies. This practice is related to our inability to judge embryonic developmental
capacity before embryo transfer. This inability is directly related to our relatively poor
understanding of the critical mechanisms controlling preimplantation development and
the impact of placing early embryos into foreign culture environments (Chambers et al.,
2007; Boulet et al., 2008).
What is clear is that cultured embryos display significant changes in gene expression
patterns, preimplantation embryo survival, implantation, fetal development, newborn
health and susceptibility to disease in later life, compared to their in vivo counterparts
(Lee et al., 2010). Although there is a relatively good understanding of the basic
mechanisms controlling preimplantation development, little is known about the
relationship between environmental cues and internal signaling events that may be
directing and regulating early development.
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1.3 Preimplantation Development
1.3.1 Preimplantation Development
Preimplantation development, also known as the “free-living” phase of development,
begins with fertilization of the mammalian oocyte and concludes with implantation of the
embryo into the uterine wall (Figure 1.1) (reviewed in Bell et al., 2008; Watson et al.,
2004). It is characterized by several molecular and morphological events required for
normal implantation and maintenance of pregnancy. It begins with fertilization of a
competent ovulated oocyte, which is fertilized in the oviduct/fallopian tube, resulting in a
one-cell zygote (Figure 1.1a)(Gosden, 2002; Sirard et al., 2006; Thelie et al., 2007).
As the preimplantation embryo travels down the oviduct/fallopian tube toward the uterus,
it undergoes a series of cell divisions resulting in a 2-cell (Figure 1.1b), 4-cell (Figure
1.1c), and 8-cell (Figure 1.1d) embryo. At the 8-16 cell stage, the cells, or blastomeres,
acquire positional significance, resulting in inside cells surrounded by an outside cell
layer. Compaction, the first morphological event, begins, resulting in a morula (16-32
cell) (Figure 1.1e) where individual blastomeres are no longer distinguishable. The
embryo then expands into a fully formed blastocyst (64 cells) (Figure 1.1f) and is now
located in the uterus. The blastocyst is comprised of blastomeres that are differentiated
into the TE (Figure 1.1f) or that remain undifferentiated within the ICM (Figure 1.1f).
Correct formation of the blastocyst is critical for successful implantation, maintenance of
pregnancy and fetal development (reviewed in Gandolfi & Gandolfi, 2001; Sirard et al.,
2006; Bell et al., 2008).
In addition to the morphological events characteristic of preimplantation development,
there are also several molecular events required for normal blastocyst formation and
implantation. Prior to fertilization, the oocyte produces and stores mRNA and proteins
required for the first embryonic cleavage division post fertilization (reviewed in Bell et
al., 2008). Transcription and storage of maternal mRNA occurs during follicular growth
but ceases as the germinal vesicle undergoes breakdown during meiosis (BreviniGandolfi et al., 1999; Gandolfi & Gandolfi, 2001; Fair et al., 2004; Bell et al., 2008). The
embryo is dependent on stored maternal mRNA until at least the maternal-embryonic
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transition (MET) when transcription of the embryonic genome begins with significant
initial output at the 2-cell stage in mice (Flach et al., 1982; Brevini-Gandolfi et al., 1999;
Gosden, 2002; Schultz, 2002; Bell et al., 2008). The embryo is now partially sustained
by its own genome, along with maternal transcripts that persist and are required for
subsequent cellular cleavages (Figure 1.2) (Alizadeh et al, 2005; Calder et al., 2008).
As the embryo travels through the oviduct towards the uterus, it undergoes a series of cell
cleavages resulting in a 4-cell embryo and then an 8-cell embryo.

Compaction is

generally initiated at the 8-cell stage in the mouse and is characterized by increased
intercellular contact between individual blastomeres. Each blastomere begins to assemble
adherens junctions (AJ) and tight junction (TJ) proteins, resulting in the formation of the
necessary cell-cell contacts that regulate blastocyst formation (Figure 1.1) (Fleming et al.,
1989). This process is coincident with another significant output of transcriptional
activity, the mid-preimplantation gene activation (MGA), and together with compaction,
is required for successful TE differentiation and blastocyst formation (Hamatani et al.,
2004)(Figure 1.2). The 16-cell compacted embryo is the first embryonic stage to consist
of both ‘inside’ cells surrounded by an ‘outside’ cell layer.

The outer cells begin

polarizing and develop both an apical and basolateral membrane.

The inner cells

continue to propagate inner daughter cells, while the outer cells can divide both
symmetrically and asymmetrically producing either two ‘outer’ daughter cells, or an
‘outer’ and ‘inner’ daughter cell respectively (Figure 1.1).
As compaction progresses, tight junctions form cell-cell contacts generating a permeable
seal around the outer cells of the embryo, allowing the embryo to accumulate water
within a nascent blastocyst cavity (Kim et al., 2004; Watson et al., 2004; Wang et al.,
2008). The blastocyst cavity enables the embryo to expand into a fully formed blastocyst.
It is during blastocyst formation where the first differentiation events are completed,
resulting in the appearance of the outer epithelial TE (Watson et al., 2004).
The blastocyst is now composed of two distinct cell types: undifferentiated cells known
as the (ICM) and a trophectoderm layer composed of extraembryonic trophoblast cells.
The ICM will later form the embryo proper (Fig 1.1.f). The TE is the first epithelium to
differentiate throughout development and is required for blastocyst formation, embryo-
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uterine interactions and is necessary for proper implantation into the uterine wall. It also
forms the embryonic portion of the placenta (reviewed in Yamanaka et al., 2006; Bell et
al., 2008).
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Figure 1.1 Mouse Preimplantation Development
As the embryo divides, the blastomeres go through symmetrical or asymmetrical cellular
divisions resulting in embryos that can have anywhere between 1-8 cells prior to
compaction.

These are representative images of some of those cleavage stages. The

oocyte is fertilized in the oviduct resulting in a 1-cell zygote (A) which then undergoes a
series of cellular divisions. (B) 2-cell stage, (C) 4-cell stage (D) 8-cell stage. It is at this
stage that compaction is generally initiated. Cellular division continues resulting in a
morula (E) where outer cells surrounding the inner cells begin polarization and TE
differentiation. It is also at this stage of development where the embryo would transit
from the oviduct to the uterus. Cellular division progresses and a fluid filled cavity is
formed resulting in an expanded blastocyst (F) with a fully differentiated TE surrounding
undifferentiated cells within the ICM. Scale bar = 10 microns.
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Figure 1.2 Characterization of Global Gene Expression Patterns During
Preimplantation Development.
The majority of maternal products (90%) that are required during oogenesis are degraded by the
2-cell stage, while the remaining maternally stored mRNAs and proteins are required for
preimplantation development. There are two main waves of embryonic gene activation during
preimplantation development corresponding with the maternal-embryonic transition (MET) and a
second mid-preimplantation development that contributes to events associated with TE
differentiation and blastocyst formation (Hamatani et al., 2004). General gene expression patterns
are indicated; loss of maternal mRNAs (red); activation of embryonic genome at the 2-cell stage
(green) and 8-cell stage (blue). Examples of genes expressed in each category are also indicated
(Adapted from Bell et al., 2008).
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1.3.2 Models of Cell Fate Determination
Two models describing how the TE and ICM are established during preimplantation
development have been proposed (Yamanaka et al., 2006). The Inside-Outside model
predicts cell fate decisions in the early embryo are determined initially by cell-to-cell
interactions so that outer cells, that have free, unopposed surfaces, begin to polarize,
while inner cells, those that are enclosed by other cells on all surfaces, do not. This
model predicts that cell fate is determined by the late morula stage, when ‘inside’ and
‘outside’ cells are fully established (Figure 1.3A). Alternatively, the Cell Polarity model
predicts that cell fate is determined at the 8-cell stage and occurs via the establishment of
an apical-basal polarity axis in each outer blastomere (Figure 1.3B). When blastomeres
undergo symmetric divisions, each daughter blastomere inherits equal components of the
mother blastomere and both resulting daughter blastomeres will contribute to the TE.
When the outer blastomeres undergo asymmetric division, each daughter blastomere
inherits a different portion of the polarized cell resulting in the production of a polarized
outer blastomere and an apolar inner blastomere (Figure 1.3B). These two models are in
some ways complimentary; however, the Inside-Outside model predicts that it is cell
position that determines cell fate, while the Cell Polarity model predicts that it is cell fate
that determines cellular position (reviewed in Yamanaka et al., 2006).
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Figure 1.3 Models of Cell Fate Determination
A)

The Inside/Outside model predicts location of the cell dictates cell fate.

B)

The Cell Polarity model predicts that molecular chemistry of a cell will dictate

cell fate. A polarized outer cell can divide either symmetrically to produce two polarized
daughter cells, which will contribute to the TE or a polarized outer cell could divide
asymmetrically and produce a polarized daughter cell, which will contribute to the TE
and an apolar daughter cell, which will contribute to the ICM. Adapted from Yamanaka
et al., 2006.
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1.3.3 Embryonic and TE Lineage Segregation
TE differentiation begins at the 8-cell stage, prior to cavitation, and occurs in cells that
maintain the expression of the zinc-fingered transcription factor caudal type homeobox 2
(Cdx2). Cdx2 is first expressed in all cells at the 8-cell stage but is segregated to the outer
cells as the blastocyst develops (Strumpf et al., 2005). Gene deletion studies of Cdx2
revealed the importance of CDX2 to TE differentiation and maintenance (Strumpf et al.,
2005). Cdx2-/- embryos cavitate and form an early blastocyst. However, the cavity
quickly collapses and the TE is not fully functional (Strumpf et al., 2005). Attempts at
deriving trophectoderm stem (TS) cell colonies from Cdx2 -/- embryos have been
unsuccessful, further demonstrating the importance of CDX2 to TE differentiation
(Strumpf et al., 2005). Cdx2-/- embryos also ectopically express embryonic lineage
specific markers in TE cells (Strumpf et al., 2005).

Taken together, these studies

demonstrate that CDX2 is a critical marker of TE specification and can be used to
determine changes to TE differentiation in the blastocyst.
Recently, it was discovered that the transcription factor TEA domain family member 4
(TEAD4) also regulates TE formation and may regulate CDX2 expression in the
preimplantation embryo (Yagi et al., 2007). Tead4-/- mice display a preimplantation
lethality and do not express CDX2. These embryos cannot form the TE and do not
produce a blastocyst cavity. They do express the undifferentiated cell marker POU class
5 homeobox 1(POU5F1, previously known as OCT4), and embryonic stem (ES) cells can
be successfully derived from Tead4-/- mice (Nishioka et al., 2007; Yagi et al., 2007).
TEAD4 expression is thus critical for TE formation and differentiation (Nishioka et al.,
2007). POU5F1 is another TF expressed at the 8-cell stage but in contrast to CDX2
expression, POU5F1 becomes segregated to the ICM in mouse blastocysts (Palmieri et
al., 1994; Niwa et al., 2005). Pou5f1-/- embryos are not able to form TE; however, upon
the addition of a POU5F1 target, Fibroblast Growth Factor 4 (FGF), TE precursors can be
re-established in the Pou5f1-/- mouse embryo (Nichols et al., 1998). POU5F1 and CDX2
are not expressed in the same cells and can be used to identify an inner mass cell versus a
trophoblast cell respectively (Nichols et al., 1998; Takahashi et al., 2007; Park et al.,
2008).
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1.3.4 Adherens Junctions and Preimplantation Development
Trophectoderm differentiation is required for blastocyst formation and is dependent on
the interaction of several molecules, such as AJs, TJs, aquaporins (AQP), the Na/KATPase and several TFs, such as CDX2 and TEAD4. Research in our lab has uncovered
the roles of some of these molecules in TE differentiation and maintenance and has
contributed to the development of a model of TE differentiation (Figure 1.4). Successful
expression and localization of AJs is critical to the proper formation of a cavitated
blastocyst (Watson et al., 2004). AJs form the intercellular connections required to
establish and maintain a mature epithelium by physically connecting adjacent cells to one
another (Figure 1.4) (Aberle et al., 1996; Baum & Georgiou, 2011). Additionally, AJs
form at the boundary of an apical-basolateral axis and are required for polarization of an
epithelium (Baum & Georgiou, 2011). AJs are composed of several molecules that
respond to mechanical and environmental stimuli while maintaining proper cell-cell
contacts (Baum & Georgiou, 2011). The structure of the AJ consists of a transmembrane
protein called cadherin-1 (CDH1; previously known as E-cadherin or Uvomorulin),
which has both an extracellular and cytoplasmic domain. The extracellular domains of
CDH1 interact with neighboring CDH1 molecules in a calcium dependent manner to
form a ‘zipper’ like structure. This interaction is necessary throughout development by
contributing to the formation of epithelial sheets and structures (reviewed in Baum &
Georgiou, 2011). Furthermore, correct AJ interaction is required to maintain epithelial
cell integrity by preventing epithelial-to-mesenchymal-transitions (EMT) which can lead
to malignancies and cancer (Shih et al., 2002; Peinado et al., 2004). The cytoplasmic
domain of CDH1 interacts with β-catenin, which in turn binds α-catenin, which anchors
the AJs to the actin cytoskeleton and other actin associated proteins such as actinin,
vinculin, formin-1, and zona occludin 1(also known as tight junction protein 1 or TJP1)
(reviewed in Baum and Georgiou, 2011; Patel et al., 2003; Thie et al., 1995; Koch et al.,
2004). The cadherin-catenin complex mediates several signaling events, including WNT
signaling through the translocation of the β-catenin complex to the nucleus (Gooding et
al., 2004; Gottardi & Gumbiner, 2001). The β-catenin complex is also responsible for AJ
recycling, which must turnover frequently to allow cells to respond quickly to changes in
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cell density or proliferation. Mature AJs must first be established before TJ complexes
are formed (Gooding et al., 2004; Gottardi & Gumbiner, 2001).
Components of AJs are detectable throughout preimplantation development from the 1cell zygote stage to the blastocyst stage and in both TE and ICM. However, it is not until
the embryo has reached the late 8-cell stage that AJs are fully assembled into functional
AJs at opposing cell borders (Figure 1.1) (Peyrieras et al., 1983; Reima, 1990; Ao &
Erickson, 1992; Clayton et al., 1993; Larue et al,. 1994; Campbell et al., 1995; Collins &
Fleming, 1995; Riethmacher et al., 1995; Ohsugi et al., 1996; Pey et al., 1998; Kanzler et
al., 2003; Nganvongpanit et al., 2006). Across several species, CDH1 itself is required for
compaction and maintenance of the blastocyst cavity, as demonstrated in both deletion
and depletion studies (Peyrieras et al., 1983; Ao & Erickson, 1992; Larue, et al., 1994;
Pey et al., 1998; Nganvongpanit et al., 2006).
Larue et al, 1994 produced Cdh1-/- mouse embryos and demonstrated that Cdh1 -/- mice
failed to maintain a normal blastocyst cavity and succumbed prior to implantation (Larue
et al., 1994). Cdh1-/- embryos undergo compaction coincident with, and at the same rate
as, normal and Cdh1+/- embryos. Cdh1-/- embryos do not arrest at compaction due to
maternally contributed CDH1, which is detectable as late as 4.5 days post coitus, or the
equivalent to the blastocyst stage (Larue et al., 1994). As normal and Cdh1+/- embryos
become blastocysts and begin to hatch, the Cdh1-/- embryos remain in the zona pellucida,
and do not hatch from the zona pellucida. If the zona pellucida is removed, Cdh1 -/embryos will undergo compaction, however, they are much less adhesive to one another
and a less tightly packed morula forms (Larue et al., 1994).
The role of CDH1 in preimplantation development was also characterized by using
dsRNA in the mouse embryo and by RNAi in the bovine embryo, resulting in similar
phenotypes as the mouse CDH1 null model (Wianny & Zernicka-Goetz, 2000;
Nganvongpanit et al., 2006). As previously discussed, AJs along with TJs form a seal
along the apical outer membrane of the embryo, which allows the blastocyst to
accumulate fluid and expand (Watson et al., 1992; Watson et al., 1999; Watson &
Barcroft, 2001; Watson et al., 2004). Taken together, these studies indicate that CDH1,

16
and more generally, AJ formation is critical for proper TE differentiation and polarization
and absolutely required for blastocyst cavitation.
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Figure 1.4 Model of the Trophectoderm
The TE is a polarized epithelial cell type that has both an apical and basolateral
membrane. TJs are located between the cells forming a seal that prevents fluid from
escaping out of the blastocyst cavity. The TJs regulate the passage of solutes across the
TE. The Na/K-ATPase maintains the electrochemical gradient across the cell membrane
by actively exchanging 3 Na+ molecules to the outside of the cell for 2 K+ molecules to
the inside of the cell. The AQPs allow the passage of water (H20) across the TE in the
presence of a low osmotic gradient created between the blastocyst cavity and the
extracellular solution. These molecules fundamentally drive TE differentiation and thus
blastocyst formation.
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1.3.5 Tight Junctions and Preimplantation Development
TJ establish the ‘seal’ surrounding the outer cells of the morula, which allows fluid to
accumulate within the blastocyst cavity (Figure 1.4) (Watson et al., 2004). Apical-basal
cell polarity is also established and maintained in epithelial cells by the correct formation
and localization of TJs. The TJ complex includes numerous proteins such as the zona
occluden proteins (TJP1, TJP2, TJP2), cingulin, claudins and occludin, that can provide
either structure, adhesion or both properties to the TJ (Fleming et al., 1989; Fleming et
al., 1993; Sheth et al., 1997; Sheth et al., 2000; Thomas et al., 2004; Moriwaki et al.,
2007). TJs are localized to the apical most region of the basolateral cell surface (Figure
1.3). TJs have two primary functions: 1) to promote and maintain cell-cell adhesion, and
2) through interaction with the actin cytoskeleton, to provide an intracellular barricade
defining and separating specialized apical and basolateral plasma membranes, known as
the ‘fence function’ (reviewed in Niessen, 2007).
TJ cell-cell adhesion enables the epithelium to act as a physical, protective barrier by
preventing molecules from passing between intercellular spaces (reviewed in Niessen,
2007). In preimplantation development, the importance of TJs is made clear as the
embryo undergoes compaction and blastocyst expansion. TJs help to establish polarity in
the developing TE and provide cell-cell adhesion points creating a barrier or ‘seal’
between the cells (Figure 1.4). This seal allows the compacted embryo to form the fluid
filled blastocyst cavity, and to expand into the blastocyst (Gualtieri et al., 1992; Fleming
et al., 2000; Kim et al., 2004).
The importance of TJs in blastocyst development has been demonstrated by inhibiting
normal TJ assembly at the 8-cell stage (Wang et al., 2008). At the 8-cell stage, embryos
have been treated with Tjp1 siRNA and Tjp1 expression has been depleted (Wang et al.,
2008). Tjp1 deficient embryos are unable to form blastocysts (Wang et al., 2008). The
barrier function of TJs has been tested by pharmacologically inhibiting two structural
components of the TJ, claudin 4 and claudin 6 (Moriwaki et al., 2007). Treated embryos
are able to compact. However, the blastomeres remained rounded and did not polarize,
resulting in the embryos failing to form expanded blastocysts (Moriwaki et al., 2007).
Furthermore, the TJ seal has also been challenged by placing inhibited embryos into
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medium containing 4.4kDa FITC molecules (known as the FitC assay) which normally
cannot move across the TJ seal. Significant accumulation of 4.4 kDa FITC occurred in
TJ inhibited embryos indicating that loss of claudin 4 and 6 is accompanied by increased
TJ permeability (Moriwaki, et al., 2007). These studies indicate that the TJs are an
essential mediator of TE differentiation, polarization and permeability (Violette et al.,
2006; Madan et al., 2007).
1.3.6 The Na/K-ATPAse and Preimplantation Development
The Na/K-ATPase is also important for cavitation and blastocyst formation (Figure 1.4).
Within the blastocyst, the Na/K-ATPase creates an ionic gradient across the TE by
pumping out three Na+ for every two K+ molecules pumped into the cell which then
promotes the movement of fluid into the blastocyst cavity (Figure 1.4) (Taniguchi et al.,
2001; Watson & Barcroft, 2001; Kidder, 2002; Watson et al., 2004). Completion of
every ionic transport cycle results in the consumption of a single ATP molecule (Baltz et
al., 1997; Boldyrev, 2001; Jorgensen & Pedersen, 2001).
The Na/K-ATPase is an oligomeric protein that maintains the osmotic gradient across the
plasma membrane of virtually all eukaryotic cells, including the preimplantation embryo
(Boldyrev, 1993; Boldyrev, 2001; Jorgensen & Pedersen, 2001; Taniguchi et al., 2001).
It consists of two main subunits, α and β, which provide the enzymatic and structural
properties to the Na/K-ATPase respectively (Boldyrev, 1993; Boldyrev, 2001; Jorgensen
& Pedersen, 2001; Taniguchi et al., 2001)
The α-subunit (ATP1A) is the catalytic subunit of the Na/K-ATPase that maintains the
Na+ and K+ ion gradient found across all plasma membranes. There are three different
isoforms of the α-subunit; ATP1A1, ATP1A2, and ATP1A3. ATP1A is properly folded
and directed to its appropriate membrane domain by its interactions with the β-subunit
(ATP1B) of the Na/K-ATPase (Ueno, et al., 1997). There are four β-subunits; ATP1B1,
ATP1B2, ATP1B3, ATP1B4. Together, the ATP1A and the ATP1B form an electrogenic
ion transporter that regulates the ionic gradient across the cell membrane. A third subunit,
the γ subunit, is a small single transmembrane protein that increases the α-subunits
affinity to ATP (Rivard et al., 2005).
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In the preimplantation embryo, Atp1a1 is expressed from the 2-cell stage onward
(Watson & Kidder, 1988; Watson et al., 1990). In the 1–cell embryo, maternal transcripts
of Atp1b1 are abundantly present but rapidly decline until the 8-cell stage when
embryonic gene expression is activated, and embryonic Atp1b1 is activated (Watson &
Kidder, 1988; Watson et al., 1990). At the protein level, ATP1B1, along with the
ATP1A1, is localized to the cortical domains of each blastomere of the mouse and bovine
preimplantation embryo from the late 8-cell stage onward (Watson et al., 1990; MacPhee
et al., 2000). While the Na/K-ATPase subunits are present throughout preimplantation
development, the appearance of detectable levels of activity has been reported to occur
just prior to compaction. Activity levels rise significantly in the late morula stage just
prior to the onset of cavitation (Biggers, et al., 1977; Wiley, 1984; Houghton et al., 2003).
The Na/K-ATPase becomes confined to the basolateral cell domain of the TE in
conjunction with TJ formation and cavitation (Watson & Kidder, 1988). In the ICM, both
subunits display an apolar distribution.
The Na/K-ATPase polarized distribution in the TE is consistent with its role as a transtrophectodermal fluid regulator (Betts et al., 1998; Watson et al., 1999; Watson et al.,
2004). Silencing of Atp1b1 expression by microinjection of siRNAs prevents blastocyst
formation and causes improper localization of TJ proteins, TJP1 and occludin, instead of
a cortical distribution pattern, these proteins are localized to the cytoplasm (Madan et al.,
2007). Atp1b1 depleted embryos also displayed abnormal ATP1A1 localization (Madan
et al., 2007). Similarly, Atp1a1-deficient embryos do not expand and form normal
blastocysts. However, this occurs only upon culture in vitro (Barcroft et al., 2004). The
Na/K-ATPase can also act as a signaling molecule, transmitting extracellular signals
across the plasma membrane to molecules in the cytoplasm. Na/K-ATPase signaling
occurs via ATP1A1 and can be activated by various cardiotonic steroids, such as ouabain
(Xie, 2001; Clausen, 2002; Espineda et al., 2004; Violette et al., 2006). When stimulated
with ouabain, the Na/K-ATPase signals via SRC family kinases (SFK), which in turn
results in a loss of TJ cohesiveness and blastocyst cavity integrity (Violette et al., 2006;
Giannatselis et al., 2011). Taken together, these results demonstrate that the Na/KATPase plays a role in regulating polarization of the TE and blastocyst formation, and
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therefore proper expression and localization of the Na/K-ATPase is critical for normal
blastocyst development.
1.3.7 Aquaporins and Preimplantation Development
Successful blastocyst expansion is dependent on the embryo’s ability to accumulate fluid
within the blastocyst cavity. Aqua-glycerol-porins (AQPs) are an essential part of this
process since they provide the channels through which fluid can move across the TE
(Figure 1.4).

The Na/K ATPase creates a small osmotic gradient across the TE.

However, the gradient is not sufficient to induce rapid osmosis into the blastocyst cavity.
AQPs therefore facilitate the movement of fluid across the TE in the presence of a weak
osmotic gradient, thereby promoting rapid blastocyst expansion (Baltz et al., 1997; Gade
& Robinson, 2006; Watson et al., 2004). AQPs are water channels representing a family
with 13 known members that are expressed in many tissues of the body, including the
preimplantation embryo (Barcroft et al., 2003; Offenberg & Thomsen, 2005; Agre, 2006;
Hara-Chikuma & Verkman, 2008). Of these, mRNAs encoding Aqp1, 3, 5, 6, 7, 8, and 9
have been detected in the preimplantation embryo (Offenberg et al., 2000). At the protein
levels, AQPs 3 and 8 are localized to the basolateral surfaces and AQP9 is present on the
apical surfaces of the trophectoderm (Barcroft et al., 2003). Together, AQP3, 8 and 9
facilitate the movement of water, small solutes, glycerol and urea across the epithelial
barrier and into the blastocoel cavity (Figure 1.4) ( Barcroft et al., 2003; Hara-Chikuma &
Verkman, 2005; Gade & Robinson, 2006; Hara-Chikuma & Verkman, 2006; Y. Liu et
al., 2007; Tait et al., 2008).
During preimplantation embryo development, AQPs contribute to the embryo’s ability to
respond to hyperosmotic stress. Blastocysts placed in KSOMaa medium + 10% glycerol
(1800 milliOsmolarity (mOsm)) initially collapse, but are able to recover their expanded
shape within 3-5 minutes. However, blastocysts placed into the same medium with a
mercuric compound used to block AQP function have reduced ability to regain an
expanded morphology. This highlights the important role AQPs play in enabling the
blastocysts to establish and maintain blastocyst expansion (Barcroft et al., 2003). AQPs
move glycerol from the external environment to the internal blastocyst cavity reducing
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the trans-trophectodermal glycerol concentration gradient. Thus, the embryo is able to
restore its normal expanded blastocyst morphology.
AQPs are part of the cellular response to osmotic stress. Aqp3 and Aqp9 expression are
up-regulated in response to hyperosmotic stress as indicated in two separate cell lines
(Sugiyama et al., 2001; Arima et al., 2003). Osmotic stress up-regulated Aqp3 expression
in human keratinocytes (Sugiyama et al., 2001). Arima et al., (2003) used rat astrocytes
as a model for studying hyperosmotic stress and found that after 6 hours, Aqp9 mRNAs
were elevated. Arima et al. (2003) determined that hyperosmotic stress increased p38
MAPK activity. This indicates that p38 MAPK may be playing a role in Aqp regulation in
response to hyperosmotic stress (Arima et al., 2003). Taken together, these studies
provide convincing evidence that Aqp expression is regulated by osmotic stress and is an
important molecule to study in regards to preimplantation development.
1.3.8 MAPK Regulation of Preimplantation Development
1.3.8.1 Mitogen Activated Protein Kinase (MAPK)
MAPKs are intracellular signaling pathways that translate extracellular stimuli into
cellular responses (Cargnello & Roux, 2011; Aouadi. et al., 2006; Bradham. et al., 2006).
They direct a wide variety of physiological processes through serine/threonine signaling.
They are ubiquitously expressed in all eukaryotic cells and are involved in such processes
as regulating gene expression, mitosis, metabolism, motility, survival, apoptosis and
differentiation (reviewed in Cargnello & Roux, 2011).

MAPK are also present in the

preimplantation embryo and have both a developmental and adaptive role by directing
embryonic responses to environmental changes (Natale et al., 2004; Y. Wang et al., 2004;
Fitzgerald et al., 2005; Madan et al., 2005; Paliga et al., 2005; Fong et al., 2007; Hickson
et al., 2007; Maekawa et al., 2007; Lu et al., 2008). This is particularly important in the
context of ART where embryos are cultured in vitro and potentially exposed to many
extracellular signals not usually encountered in the reproductive tract.
There are two main MAPK pathways, the conventional pathways and the atypical
pathways (Cargnello & Roux, 2011). The conventional pathways consist of ERK1/2,
JNK1/2/3 and p38 (α,β,γ,δ), and ERK5, and the atypical pathways consist of ERK3/4,
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ERK7, and the Nemo-like kinases (Cargnello & Roux, 2011). The conventional MAPK
pathways have been characterized throughout preimplantation development and therefore
my studies focus solely on elucidating the role of the conventional MAPK pathways and
will therefore be referred to as MAPK. MAPKs are activated through a conserved three
stage cascade of phosphorylating kinases; a MAPK, a MAPK kinase (MAPKK) and a
MAPKK kinase (MAPKKK) (Figure 1.5) (Adapted from Bell et al., 2008). MAPKKK
are activated by extracellular stimuli through phosphorylation events occurring by
interacting with small GTP-binding proteins of the Ras/Rho family.

MAPKKK

subsequently phosphorylates MAPKK, which then phosphorylates MAPK which then
orchestrates a cellular response (Figure 1.5) (Reviewed in Kyriakis & Avruch, 2001;
Cargnello & Roux, 2011).
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Figure 1.5 MAPK Signaling
The three conventional MAPK pathways are expressed during preimplantation
development.

They help mediate the embryonic response to environmental stimuli,

including stress.

Each pathway can be inhibited using specific pharmacological

inhibitors that act either directly upon the MAPK kinase (such as SB 220025, which acts
upon p38 MAPK), or upstream mediators of the pathway (such as U0126, which inhibits
MAPKK from activating ERK) (Reviewed in Cargnello & Roux, 2011; Duncia et al.,
1998; Jackson et al., 1998).
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1.3.8.2 ERK MAPK and Preimplantation Development
The mammalian ERK pathway was the first of the MAPK pathways to be characterized
(Boulton et al., 1991; Cargnello & Roux, 2011). There are two isoforms of ERK, ERK1
and ERK2, which share approximately 83% amino acid identity. They are expressed in
all tissues, predominantly though in the brain, skeletal muscle, thymus and heart
(Reviewed in Cargnello & Roux, 2011; Kyriakis & Avruch, 2001). ERK1/2 plays a
critical role in cell proliferation, from controlling cell-cycle progression to the regulation
of early response genes (Reviewed in Cargnello & Roux, 2011).

ERK1/2 can be

activated by various stimuli including growth factors, G protein-coupled receptor
activation, cytokines, osmotic stress and microtubule disorganization. ERK1/2 are
localized cytoplasmically; however, upon stimulation, they primarily accumulate in the
nucleus (Chen et al., 2005).

The ERK pathway can be inhibited using the

pharmacological agents U0126 and PD98059 (Duncia et al., 1998; Jackson et al., 1998).
These inhibitors target MAPKK, MEK1 and MEK2 which in turn phosphorylate ERK1/2
when the pathway is stimulated. The inhibitors’ mode of action is to interact with the unphophorylated species of MEK1 and MEK2, preventing future phosphorylation and thus
inhibiting the propagation of the signaling cascade (Duncia et al., 1998).
Although ERK1/2 are present throughout preimplantation development, the role that they
play is still relatively unclear. The ERK pathway plays a role in implantation and
trophoblast invasion into the uterine wall by the blastocyst (Reviewed in Fitzgerald et al.,
2005). Inhibition of the ERK pathway does not prevent blastocyst formation, but it may
play a role in TE differentiation (Jackson et al., 1998; Paliga et al., 2005; Lu et al., 2008).
ERK is localized to the apical membrane of each blastomere at the 8-cell stage and
inhibition of the ERK pathway causes a visible decrease in CDX2 detection, a TF
required for TE differentiation and maintenance.

After ERK inhibition, blastocyst

formation was delayed and trophoblast outgrowths were impaired (Lu et al., 2008).
These results do indicate that the ERK pathway is present throughout preimplantation
development and warrants further study.
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1.3.8.3 JNK/SAPKs and Preimplantation Development
There are three isoforms of JNK/SAPK, JNK1, JNK2, and JNK3 and they are 85%
identical with each other. JNK1 and JNK2 are expressed in various tissues, however
JNK3 is abundantly expressed in testes, neuronal tissues and cardiac myocytes (reviewed
in Cargnello & Roux, 2011). The JNK pathway is activated by a number of different
stresses, including UV radiation, cytokine treatment, heat shock and radiation (reviewed
in Aouadi et al., 2006). Activation of the JNK pathway has been studied through the use
of pharmacological inhibitors such as SP600125 and AS601245 (Bogoyevitch et al.,
2010).

These inhibitors are ATP competitive blockers and have been widely used to

study the JNK pathway (Bogoyevitch et al., 2010).
JNK/SAPK is present and active in the preimplantation embryo, and does play a role in
mediating development in in vivo derived blastocysts (Zhong et al., 2004; Xie et al.,
2006; Xie et al., 2007). To investigate the effects of culture media on activation of the
JNK/SAPK pathway, embryos were placed in either “optimized” media (Potassium
Simplex Optimized Media with amino acids (KSOMaa)) or “poor” media (Ham’s F10) in
the presence of a JNK/SAPK inhibitor.

It was reported that embryos cultured in

“optimized” KSOMaa media in the presence of the JNK/SAPK inhibitor had reduced
apoptosis at the blastocyst stage, and developed at a faster rate than the embryos cultured
in KSOMaa media alone. Embryos cultured in the “poor” Ham’s F10 media in the
presence of the JNK/SAPK inhibitor developed poorly compared to embryos cultured in
Ham’s F10 alone. This indicates that the JNK/SAPK pathway is required to help maintain
homeostasis when embryos are cultured in suboptimal media, but not when embryos are
cultured in optimized media.

The JNK/SAPK MAPK pathway therefore does not

necessarily play a role during development but does mediate the responses of early
embryos to environmental stress (Xie et al., 2006).
1.3.8.4 P38 MAPKs and Preimplantation Development
The p38 MAPK family consists of 4 isoforms, α (MAPK-14), β (MAPK-11), γ (MAPK12), δ (MAPK-13) where MAPK-14 and MAPK-11 isoforms are more ubiquitously
expressed than the MAPK-12 and MAPK-13 isoforms (Reviewed in Cargnello & Roux,
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2011). The four different isoforms affect downstream targets involved in transcription,
mRNA stability, or translation (Jiang et al., 1996; Sudo et al., 2005; Cargnello & Roux,
2011). The p38 MAPK pathway is involved in the production of cytokines in response to
inflammation, as well as in cell proliferation and cell survival (Reviewed in Cargnello &
Roux, 2011). It is activated by stress from cytokines, osmotic stress, oxidative stress and
various other environmental cues (Reviewed in Duzgun et al., 2000; Ono & Han, 2000;
Kyriakis & Avruch, 2001; Arima et al., 2003; J. Liu et al., 2004; Natale, et al., 2004;
Song et al., 2005; Aouadi et al., 2006; Bradham & McClay, 2006; Fong et al., 2007;
Hickson et al., 2007; Hara-Chikuma & Verkman, 2008; Cargnello & Roux, 2011). While
the pathway is inactive, p38 isoforms are detected in both the cytoplasm and the nuclei.
However, upon stimulation, these isoforms accumulate in the nuclei (Cargnello & Roux,
2011).
There are several inhibitors available that selectively target MAPK-14 and MAPK-11
(Jackson et al., 1998). These inhibitors include SB 203580 and SB 202190 which are
ATP-competitors; SB 220025, which binds to the enzymatic site of MAPK-14 and
MAPK-11, as well as a fourth inhibiter, BIRB079, which indirectly competes with ATP
binding (reviewed in Jackson et al., 1998; Cargnello & Roux, 2011). Of these, SB
220025 has been extensively utilized to elucidate the role of p38 MAPK throughout
preimplantation development (Natale et al., 2004; Madan et al., 2005; Paliga et al., 2005;
Fong et al., 2007; Hickson et al., 2007). SB 220025 (5-(2-Amino-4-pyrimidinyl)-4-(4fluorophenyl)-1-(4-piperidinyl) imidazole) belongs to a group of compounds known as
cytokine suppressive anti-inflamatory drugs (CSAIDs). CSAIDs are ATP-competitors
that specifically bind to the ATP-active pocket of unphosphorylated or phosphorylated
forms of p38 MAPK, preventing its ability to phosphorylate downstream targets, or to
autophosphorylate (Frantz et al., 1998; Wang et al., 1998). CSAIDs block the p38
MAPK cascade, which results in decreased production of cytokines, such as TNF-α and
IL-1β. SB 220025 inhibits p38 phosphorylation of a downstream target, EGFR. The IC50
of SB 220025 was 50 nM using EGFR as a read-out. SB 220025 has a 1000-fold greater
selectivity for p38 MAPK over ERK MAPK (Jackson et al., 1998).
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SB 220025 has been used to study the role of p38 MAPK throughout cleavage stage
development (Natale et al., 2004; Paliga et al., 2005). Embryos were cultured from the 2cell stage in SB 220025 and allowed to develop normally. Treated embryos resulted in a
reversible, developmental arrest at the 8-16 cell stage, compared to untreated embryos
which formed blastocysts (Natale et al., 2004). Once the pharmacological inhibitors were
removed, embryos resumed their developmental program and progressed normally to the
blastocyst stage. Inhibition of the p38 MAPK pathway resulted in loss of phospho-HSP,
which is required to stabilize filamentous actin (Natale et al., 2004; Paliga et al., 2005).
Once the inhibitor was removed, phospho-HSP returned and filamentous actin was
properly stabilized, resulting in the embryo being able to resume the proper
developmental program (Natale et al., 2004; Paliga et al., 2005). These results support
the hypothesis that p38 MAPK activity is important for blastocyst development.
Furthermore, p38 MAPK can phosphorylate CDX2 and act as a positive regulator during
intestinal epithelial cell differentiation (Houde et al., 2001). However, the effect of p38
MAPK on CDX2 expression in the TE has yet to be investigated. P38 MAPK may also
play a role in the preimplantation embryo’s ability to respond to stress in the culture
media. When embryos are exposed to hyperosmotic stress for 15 minutes, the p38
MAPK pathway is activated (Fong et al., 2007). The MAPKAPK2, a downstream target
of p38 MAPK and an appropriate indicator of p38 MAPK activity, is more highly
phosphorylated in embryos exposed to hyperosmotic culture medium than embryos
cultured in KSOMaa.

This elevation in phosphorylation is extinguished when the

embryos are cultured under hyperosmotic conditions in the presence of SB 220025,
confirming that p38 MAPK is activated in response to hyperosmotic stress (Fong et al.,
2007; Alizadeh et al., 2005; Bultman et al., 2006; Pennetier et al., 2006; Tang et al.,
2007; Thelie et al., 2007; Bettegowda et al., 2008; Hamatani et al., 2008; Vallee et al.,
2008; Yurttas et al., 2008).
Additionally, p38 MAPK mediates phosphorylation of EZRIN, a molecule involved in
apical microvilli length as well as polarization during embryonic compaction, in an
oncogenic RAF-1-transfected mouse hepatic cell line (Lan et al., 2006).

Upon

transfection of RAF-1 into the mouse hepatic cell line, EMT was demonstrated by
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increased Snai1 and decreased Cdh1 expression. As well, Ezrin was down-regulated and
there was a loss of microvilli. Inhibition of p38 MAPK using SB 203580, in RAF-1
treated cells, restored the normal expression of Cdh1, Snai1, Ezrin and the number of
microvilli (Lan et al., 2006).
P38 MAPK is also involved in regulated Cdh1 expression during gastrulation (Zohn et
al., 2006). During gastrulation, p38 MAPK is required for Cdh1 down-regulation during
mesoderm migration. However, this process is independent of SNAI1 regulation of Cdh1.
Taken together, these results demonstrate some of the multiple ways that p38 MAPK
signaling can regulate embryonic development and cellular responses to stimuli.
1.3.9 Downstream Targets of p38 MAPK: Snai1 and Snai2
The p38 MAPK pathway regulates downstream expression of several TFs, including
Snai1 and Snai2. SNAI1 and SNAI2 are two TFs involved in wound repair and in EMT
(Cho et al., 2007; Dhasarathy et al., 2007; Hotz et al., 2007). Aberrant expression of
Snai1 and Snai2 is linked to metastasis in epithelial cell lines (Batlle et al., 2000; Hotz et
al., 2007; Moreno-Bueno et al., 2006). SNAI1 and SNAI2 direct the loss of polarity in
epithelial cells by down-regulating Cdh1, Tjp1 and Occludin expression, resulting in the
loss of cell-cell contacts and EMT (Batlle et al., 2000; Bolos et al., 2003; Cano et al.,
2000; Ikenouchi et al., 2003; Moreno-Bueno et al., 2006). Once EMT has occurred, and
a cell is no longer bound to surrounding cells, it can potentially proliferate and become a
metastasizing cancerous cell. EMT is induced by several growth factors, including
transforming growth factor beta (TGFβ) and fibroblast growth factor 4 (FGF4), which
also regulate Snai1 and Snai2 expression (Hotz et al., 2007; Rukstalis & Habener, 2007;
Yoshino et al., 2007).
The p38 MAPK pathway is involved in mediating the response to stress in ovarian cancer
cell lines (Cheng et al., 2010; Strippoli et al., 2010). The p38 MAPK pathway regulates
Cdh1 expression in response to EGF stimulation via SNAI1 but not SNAI2 in human
ovarian cancer cells (Cheng et al., 2010). When ovarian cancer cells are stimulated using
EGF in the presence of a p38 inhibitor (SB 203580) or p38 α siRNA, there is a decrease
in expression of Snai1 and Cdh1 (Cheng et al., 2010). The p38 MAPK pathway also
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plays a role in EMT. EMT is induced in human mesothelial cells by using TGF-β
(Strippoli et al., 2010). Cells pre-treated with the p38 MAPK pharmacological inhibitor,
SB 203580 prior to EMT induction results in decreased Snai1 expression which indicates
a role for the p38 MAPK pathway in regulating Snai1 (Strippoli et al., 2010).
SNAI1 and SNAI2 also regulate Atp1b1 expression in MDCK cells (Espineda et al.,
2004). As SNAI1 increases in MDCK cells, Atp1b1 expression decreased, indicating that
it is down-regulated by SNAI1. Increased SNAI1 also results in down-regulated Cdh1
expression and the loss of cell-cell contacts (Espineda et al., 2004). Conversely, increased
SNAI2 promotes Atp1b1 expression by inhibiting Snai1 expression (Espineda et al.,
2004). Taken together these data indicate the p38 MAPK pathway may play a role in
regulating blastocyst formation protein through the regulation of Snai1 and Snai2 TFs.
1.3.10 Culture Effects on Preimplantation Development
The goal of embryo culture is to produce viable embryos for implantation while
minimizing the perturbation embryos might encounter during in vitro culture. The
development of culture media has provided much insight into the susceptibility of the
preimplantation embryo to perturbation to its environment. Through the addition and
elimination of materials in culture media, including serum, proteins, amino acids, as well
as changes to the culture atmosphere, such as hypoxia, temperature, and pH, research has
been able to elucidate the windows in which environmental perturbation cause permanent
changes to the developmental potential of an embryo (Gardner 1992; Gardner et al.,
1993; Gardner et al., 1994).
The first media component to be identified as contributing to aberrant embryo
development was the addition of serum to embryo culture media (reviewed in Thompson
et al., 2007). Serum is routinely used in cell culture and initially, seemed to have
beneficial effects to preimplantation embryo development (Reviewed in Thompson et al.,
2007; Walker et al., 1992). However, both sheep and cattle offspring from serum culture
embryos displayed higher than normal birth weights resulting in the phenomenon known
as Large Offspring Syndrome (reviewed in Thompson et al., 2007). Sheep produced with
culture medium containing serum have, on average, 20% higher birth weights and
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gestation length extended by two days (Walker et al., 1992). Other adverse health
outcomes in these sheep included higher incidents of neonatal deaths and abnormalities in
limb development (reviewed in Thompson et al., 2007; Walker et al., 1992). In the
mouse, embryos cultured in the presence of serum are born significantly smaller than
their non-serum cultured counterparts and have increased fetal mortality (Reviewed in
Bowman & McLaren, 1970; Arny et al., 1987; Khosla et al., 2001).

Observable

consequences to embryos cultured in the presence of serum occur as early as the
blastocyst stage with changes in morphology, such as reduced compaction, early embryo
blastulation and greater cytoplasmic fragmentation, as well as changes in metabolism
including blastocyst consumption of metabolites, serum lipoprotein accumulation in the
cytoplasm of the blastomeres, higher rate of glycolysis, a lower level of glucose oxidation
and increased mitochondrial degeneration

(Reviewed in Thompson et al., 2007;

Thompson et al., 1991; Walker et al., 1992; Gardner et al., 1994; Rizos et al., 2002;
Shamsuddin & Rodriguez-Martinez, 1994). Media that could support blastocyst
development as successfully as serum-supplemented media were then developed and
several factors for successful embryo development were uncovered (reviewed in
Thompson et al., 2007; Gardner et al., 2008). These included a beneficial role of adding
amino acids and a deleterious role of ammonia, a waste by-product of amino acid
metabolism (Gardner et al., 1994; Gardner et al., 1993; Lane and Gardner 1992).
Exposure to ammonia during the cleavage stage of development results in developmental
abnormalities as well as altered expression of the imprinted gene H19 (Reviewed in Lane
and Gardner 2001; Thompson et al., 2007). Embryo development blocking at the two-cell
stage was also an obstacle. Embryos were able to be cultured from the two cell stage to
the blastocyst stage, but were unable to be cultured directly from the one-cell stage as
they would arrest at the two-cell stage. As media improved, the osmolarity was also
reduced from approximately 300 mOsm to 265mOsm, and organic osmolytes such as
glycine were added, and the 2-cell block was overcome (Baltz et al., 2010). Optimizing
culture media is still an ongoing process.
Effects to blastocyst development and fetal weight are readily observable consequences
to culture effects. Recent studies however have revealed adverse effects in behavior and
in long term health in cultured embryos as well (Ecker et al., 2004; Watkins et al., 2007).
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These include raised systolic blood pressure in later adult life in both male and female
mice and increased anxiety and decreased memory retention in mice derived from
cultured embryos (Ecker et al., 2004). Consequences of embryo culture on epigenetic
reprogramming have been proposed as a mechanism that accounts for these permanent
and long-lasting health effects (reviewed in Khosla et al., 2001; Thompson et al., 2007).
Epigenetic alterations linked to the addition of serum to culture medium include reduced
expression of insulin-like growth factor-2-receptor, which is related to Large Offspring
Syndrome (Powell et al., 2006; Young et al., 2001). Additionally, human imprinting
diseases, such as Beckwith-Wiedemann syndrome and Angelmann syndrome, are also
more prevalent in children produced through ART (Reviewed in Thompson et al., 2007;
Reviewed in Khosla et al., 2001).
The culturing of embryos often produces more embryos than required for each round of
ART. These embryos are then frozen and stored in liquid nitrogen until they are required,
at which point they are thawed.

This process exposes embryos to high levels of

hyperosmotic cryoprotectant media consisting of glycerol and sucrose. Sucrose acts to
draw water out of the cells, while glycerol can pass through the cell membrane via the
AQP, replacing water, and acting as a cryoprotectant against the cellular damages that
freezing can cause (Leibo et al., 2011).
Although these studies and technologies reveal some of the initial and long-lasting effects
of the in vitro environment on embryo development and health, the mechanism of how
environmental perturbations cause permanent changes have yet to be elucidated. My
studies focus on the MAPK pathways, signal transduction pathways that mediate
embryonic responses to environmental changes, as an important aspect to understanding
embryonic adaptability to environmental insults.
1.4 Proposed Model of MAPK Regulation of TE Associated Proteins
Understanding the molecular mechanism governing blastocyst development and response
to culture stress is essential. P38 MAPK has both a developmental role and an adaptive
role throughout preimplantation development. Understanding the role of the p38 MAPK
pathway in the blastocyst will provide further insight into blastocyst formation and
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adaptability. I have proposed a model for the roles of MAPK pathways in mediating
preimplantation development, blastocyst formation and embryonic response to culture
stress (Figure 1.6). In this model, the JNK/SAPK pathway regulates apoptosis following
exposure to hyperosmotic medium during preimplantation development. The p38 MAPK
pathway also contributes to the regulation of apoptosis, as well as regulating Aqp3 and
Aqp9 expression. Finally, the p38 MAPK pathway regulates blastocyst development by
signaling through known targets, SNAI1 and potentially SNAI2, which in turn regulate
CDH1, TJP1, OCCLUDIN and ATP1B1 (Figure 1.6).
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Figure 1.6 Proposed Model of MAPK Regulation of TE Associated Proteins in
Response to Stress and Development
This model predicts that the p38 MAPK pathway and the JNK/SAPK pathway regulate
apoptosis in response to stress. It predicts that the p38 MAPK pathway also regulates
Aqp3 and Aqp9 expression in response to stress but not during development. It predicts
that the p38 MAPK pathway contributes to blastocyst formation by regulating SNAI1 and
SNAI2, which in turn regulate the Na+/K+-ATPase, which regulates TJs. Green arrows
indicate transcriptional regulation; Purple arrows indicate activation; Red bars indicate
inhibition; Blue circles represent nuclei.
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1.5 Objectives and Hypothesis
My overall hypothesis is that the MAPK pathways regulate TE associated proteins and
apoptosis in response to culture stress and may regulate other TE associated proteins by
affecting SNAI1 and SNAI2 expression or localization during blastocyst formation.
1.5.1 Chapter Two: “MAPK Regulation of Aquaporin (AQP) Expression and
Embryonic Apoptosis Following Exposure to Hyperosmotic Conditions.”
Rationale: Previous studies have demonstrated that AQP3 and 9 are present and
functional in the preimplantation embryo (Barcroft et al., 2003). Studies have also
indicated that the p38 MAPK and JNK/SAPK pathways are present and that the p38
MAPK pathway is activated in response to hyperosmotic stress in the preimplantation
embryo (Wang et al., 2005; Xie et al., 2006; Xie et al., 2007; Fong et al., 2007).
Hypothesis: The p38 MAPK and JNK/SAPK pathways regulate Aqp expression and
apoptosis following exposure to hyperosmotic medium during preimplantation
development.
Objectives: Determine (1) the effects of culture medium hyperosmolarity on Aqp gene
expression and apoptosis, and (2) the role of the MAPK and JNK/SAPK pathways on
Aqp gene expression and apoptosis using pharmacological inhibitors.

1.5.2 Chapter Three: P38 MAPK Regulates Cavitation and Tight Junction Function in
the Mouse Blastocyst

Rationale: The p38 MAPK pathway has both a developmental and adaptive role
throughout preimplantation development. The preimplantation embryo cannot progress
beyond the 8-16 cell stage if the p38 MAPK pathway is blocked at the 8-cell stage
(Natale et al., 2004; Paliga et al., 2005). However, the role of p38 MAPK regulation of
blastocyst formation and TE maintenance has not been studied.
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Hypothesis: The p38 MAPK pathway regulates blastocyst expansion, hatching and TE
differentiation.

Objective: Determine the effects of p38 MAPK inhibition on blastocyst cavitation and
expansion, hatching frequency and apoptosis levels, TJ permeability, TJP1 localization
and distribution, TE differentiation and polarization, and Aqp3 expression and AQP3
localization.

1.5.3 Chapter Four: SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell
Stage and Become Segregated to the TE in the Mouse Blastocyst.
Rationale: The p38 MAPK pathways regulate CDH1 and TJP1 in response to stress via
SNAI1 (Grotegut et al., 2006; Lan et al., 2006). Furthermore, SNAI1 and SNAI2 are
involved in regulating the Na/K-ATPase, another blastocyst formation associated protein
(Espineda et al., 2004). However, little is known about the regulation of Snai1I and Snai2
during preimplantation development.

Hypothesis: The p38 MAPK pathway regulates blastocyst development by signaling
through known targets, SNAI1 and potentially SNAI2, which in turn regulate CDH1,
TJP1, OCCLUDIN and ATP1B1.

Objective: Characterize SNAI1 and SNAI2 expression and localization throughout
preimplantation development.
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CHAPTER TWO

MITOGEN-ACTIVATED PROTEIN KINASE (MAPK)
PATHWAYS MEDIATE EMBRYONIC RESPONSES TO
CULTURE MEDIUM OSMOLARITY BY REGULATING
AQUAPORIN 3 AND 9 EXPRESSION AND LOCALIZATION,
AS WELL AS EMBRYONIC APOPTOSIS.
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2.1 Introduction
Understanding the interactions between the early embryo and its external environment is
critical to developing optimal culture environments for the production of preimplantation
embryos and also for understanding the developmental program that controls
preimplantation development. Assisted reproductive technologies have long sought to
mimic the environment of the reproductive tract to minimize the environmental stress on
the preimplantation embryo when cultured in vitro (Diamond et al., 1991; Leese et al.,
1998; Kwong et al., 2000; Bogdarina et al., 2007). Our studies have revealed that up to
seven members of the Aquaporin (AQP) gene family are expressed throughout
preimplantation development (Offenberg et al., 2000) and that AQPs are likely to
function in facilitating the trans-trophectoderm fluid movements that occur during
cavitation which result in the formation of the fluid-filled cavity of the blastocyst
(Barcroft et al., 2003). AQPs are water channels and represent a family with 13 known
members that are expressed in many tissues including the kidneys, lungs and uterus
(Hoffert et al., 2000; Offenberg et al., 2000; Barcroft et al., 2003; Agre, 2006; HaraChikuma and Verkman, 2008). AQPs, such as AQP 3 and 9 are aquaglyceroporins and in
addition to water, these transmembrane proteins allow the passage of small solutes such
as urea and glycerol across the cell membrane (Rivard et al., 2005).

More recently, our studies have investigated p38 mitogen-activated kinase (MAPK11/14)
pathway expression and function during preimplantation development (Natale et al.,
2004; Paliga et al., 2005; Fong et al., 2007; Hickson et al., 2007; Madan et al., 2007).We
have discovered that MAPK11/14 is required to support development beyond the 8–16
cell stage in the mouse and that MAPK11/14 is also activated in response to embryonic
exposure to hyperosmotic medium (Natale et al., 2004; Paliga et al., 2005; Fong et al.,
2007). Xie et al. (2007) reported increased activation of MAPK11/14 and MAPK8
(previously known as the JNK/SAPK pathway) pathways in embryos cultured in poor
media compared with those cultured in optimized media. Xie et al. (2007) also showed
that embryos cultured in less optimal conditions had higher levels of apoptosis than those
cultured in optimized media. Culture medium osmolarity is an important parameter that
must be defined to provide embryos with appropriate environments in which to develop
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in vitro. Studies conducted primarily in Dr(s) Baltz’ and Gardner’s laboratories have
demonstrated that in vivo reproductive tract environments expose embryos to what would
be considered to be hyperosmotic environments for cultured embryos (Gardner and
Leese, 1990; Collins and Baltz, 1999). It has been determined that amino acid
concentrations, in particular glycine levels, in the oviduct serve as osmolytes to allow for
embryo development in 300–350 mOsm environments in vivo (Steeves et al., 2003;
Steeves and Baltz, 2005). In vitro preimplantation embryos cultured in 300 mOsm culture
medium do not normally progress to the blastocyst stage. However, we have discovered
that MAPK11/14 activity is elevated only when embryos are cultured in hyperosmotic
sucrose medium and not in hyperosmotic glycerol medium (Fong et al., 2007). We
propose that exposure to hyperosmotic conditions would increase the ionic gradient
across the plasma membrane and this may provide a stimulus for enhanced expression of
AQPs in an attempt to alleviate osmotic stress. Since the AQPs expressed during
preimplantation development include the aquaglyceroporins AQP 3 and 9, we have
investigated the influences of exposure to hyperosmotic culture medium on AQP mRNA
levels and protein distribution using either sucrose or glycerol to produce hyperosmotic
media. Embryos, and somatic cells in general, do not have the ability to transport sucrose
across the plasma membrane, however, the existence of aquaglyceroporins provides early
embryos and somatic cells with an avenue for moving glycerol across the plasma
membrane. In addition, we have investigated the influences of exposure to hyperosmotic
medium on blastocyst apoptosis and characterized the role of MAPK11/14 and the
MAPK8 pathways in mediating the responses to hyperosmotic culture media. The early
mouse embryo provides an ideal model to investigate the effects of environment on the
regulation of AQP expression and function. This cellular model affords an opportunity to
define the signaling pathways controlling AQP expression and function. Our results
indicate that AQPs are important mediators of embryonic adaptive cellular responses to
hyperosmotic stress. We have determined that AQP expression and localization is
primarily regulated by the MAPK14/11 pathway, whereas apoptosis is primarily
controlled by the MAPK8 pathway.
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2.2 Materials and Methods
2.2.1 Ovulation Induction and Mouse Embryo Collection

Female MF-1 mice (Charles River, Canada; 3–5 weeks old) were injected with 5 IU
PMSG (Intervet Canada Ltd, Whitby, Ontario, Canada), followed by 5 IU hCG (Intervet)
47 h later and mated with CD-1 males. Successful mating was determined the following
morning (Day 1) by the detection of a vaginal plug. Time post-hCG was used to measure
the developmental age of the embryos. Preimplantation mouse embryos were flushed
from the reproductive tract using M2 flushing media (Sigma, St Louis, MO, USA) at 65–
68 h (8-cell and compacting 8-cell) post-hCG. Embryos were then washed four to five
times in 50 ml drops of potassium simplex optimized medium with amino acids
(KSOMaa, Chemicon, Temecula, CA, USA) and transferred to 20 µl drops of KSOMaa
(Jones et al., 1997) or hyperosmotic treatment media, under light paraffin oil. They were
maintained in culture under 5% CO2 in air atmosphere at 37ºC for 3, 6 or 24 h. Animal
care and treatment followed protocols established by the UWO animal care committee.

2.2.2 Hyperosmotic Media

Hyperosmotic media were prepared by the addition of sucrose or glycerol to KSOMaa
medium. The treatment groups consisted of (i) KSOMaa (control, 265 mOsm); (ii)
KSOMaa + 0.023 g/ml sucrose (300 mOsm); (iii) KSOMaa + 0.032 g/ml sucrose (350
mOsm); (iv) KSOMaa (1 ml) + 0.3 ml (1.26 g/ml) glycerol (300 mOsm) and (v)
KSOMaa (1 ml) + 0.7 ml (1.26 g/ml) glycerol (350 mOsm). The osmolarity of the
embryo culture medium was tested by freezing-point depression using an Advanced
Model 3320 MicroOsmometer (Advanced Instruments Inc., Norwood, MA, USA).

2.2.3 MAPK14/11 and MAPK8 Inhibition

SP600125, MAPK8 inhibitor negative control inactive analog, SB220025 and SB202474
were purchased from Calbiochem (La Jolla, CA, USA). All compounds were dissolved in
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dimethylsulfoxide (DMSO) to make stock concentrations of 10 mM and were stored at 20ºC. Pools of 20 embryos were cultured for 6 or 24 h in 20 µl drops of either (i)
KSOMaa plus 0.1% DMSO; (ii) KSOMaa plus 2–10 µM SB220025 (CSAID, active
MAPK14/11 inhibitor); (iii) 300 mOsm sucrose hyperosmotic media plus 2–10 µM
SB220025; (iv) 350 mOsm sucrose hyperosmotic media plus 2–10 µM SB220025; (v)
KSOMaa plus 10 µM SB202474 (CSAID, inactive analog) (Natale et al., 2004; Paliga et
al., 2005; Fong et al.,2007); (vi) KSOMaa plus 10 µM SP600125 (active MAPK8
inhibitor) (Xie et al., 2006) or (vii) 300 mOsm sucrose hyperosmotic media plus 10 µM
SP600125; (viii) 350 mOsm sucrose hyperosmotic media plus 10 µM SP600125; (ix)
KSOMaa plus 10 µM MAPK8 inhibitor negative control inactive analog (CSAID,
MAPK8 negative control inactive analog).

2.2.4 RNA Extraction

Total RNA was extracted from the pools of 20 embryos or from positive control tissue
(mouse heart, liver and kidney; 1 mg). Samples were frozen and stored at -80ºC in 5 µl of
lysis buffer and processed as outlined in a Microeasy RNA isolation Kit protocol
(Qiagen, Mississauga, Ontario, Canada) following collection. In samples used for realtime reverse transcription and polymerase chain reaction (RT–PCR) analysis, 0.025
pg/embryo of exogenous Luciferase control RNA (Promega Corporation, Madison, WI,
USA) containing a 30-base poly(A) tail was added to each pool of embryos prior to RNA
extraction. This was done to be able to compare mRNA level between pools of embryos
at different stages.

2.2.5 Reverse Transcription and Polymerase Chain Reaction

Embryo total RNA was reverse transcribed (RT) using Random Primers (Invitrogen Life
Technologies, Burlington, ON, Canada) and RNaseOUTTM Ribonuclease Inhibitor
(Invitrogen Life Technologies) along with Sensiscript RT (Qiagen) according to the
manufacturer's suggested protocol. Following 1 h incubation, the sample was diluted to a
concentration of one embryo equivalent per microliter (embryo/µl) and subjected to PCR
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amplification of Luciferase, to determine the efficiency of the RNA extraction and
reverse transcription prior to investigation of expression of the target genes by real-time
PCR amplification.
2.2.6 Custom TaqMan® Gene Expression Assay Design for Real-Time PCR
The Custom TaqMan® primer and probe sets for Luciferase were designed using the
Assays-by-Design File Builder program (Applied Biosystems, Foster City, CA, USA).
The probe sequence for luciferase was directed against a target site 550 bp into the fulllength sequence used to generate the Luciferase Control RNA (Promega Corporation).
The target site specifies an approximate location for the generation of a TaqMan® probe,
and each target site was verified to be unique by performing the BLAST ® analysis. Duallabeled probes were synthesized (Applied Biosystems) to contain the reporter dye 6carboxyfluorescein (6-FAM) at the 5' end and a non-fluorescent quencher dye at the 3'
end.
2.2.7 Real-time RT–PCR Analysis
Real-time RT–PCR was performed using the ABI PRISM® 7900HT sequence detection
system (Applied Biosystems) and TaqMan® gene expression assays (Applied
Biosystems). Pre-designed and pre-optimized commercially available TaqMan® gene
expression assays for Aqp 3 (Assay ID: mm01208559_m1), and 9 (Assay ID:
mm00508094_m1), were used along with the Custom TaqMan® gene expression assays
described above for Luciferase. The PCR mixture (50 µl) contained 25 µl of TaqMan®
Universal PCR Master Mix (2x concentration, containing AmpliTaq Gold® DNA
Polymerase, AmpErase® UNG, dNTPs with dUTP, Passive Reference 1 and optimized
buffer components; Applied Biosystems), 2.5 µl of the appropriate 20x TaqMan® gene
expression assay (see above), 10 µl of embryo cDNA (at a diluted concentration of 0.1
embryo/µl) corresponding to one embryo equivalent per reaction and 12.5 µl of
HyPureTM Molecular Biology Grade Water (HyClone, Logan, UT, USA). Thermal
cycling conditions were 50°C for 2 min and 95°C for 5 min, followed by up to 60 cycles
of 95°C for 15 s, and a combined annealing extension stage, 60°C for 1 min. Each
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reaction was performed in triplicate on ABI PRISM® 96-well optical reaction plates
(Applied Biosystems). Relative quantification of target gene expression levels was
performed using the comparative CT (threshold cycle) method (ABI PRISM® sequence
detection system, version 2.1, Applied Biosystems). The quantification was normalized to
the control luciferase RNA levels (Li et al., 2005). Within the log linear phase region of
the amplification curve, the difference between each cycle was equivalent to a doubling
of the amplified product of the PCR. The CT value was determined by subtracting the
control CT value for each sample from the target gene CT value of the sample. Calculation
of CT used KSOMaa control treatment as the standard for determining fold-changes in the
relative mRNA expression of the target gene using the formula 2–CT.
2.2.8 Antisera
Immunolocalization of AQP 3 and 9 in treated 8-cell embryos was determined by using
proven commercially available primary antibodies from Alpha Diagnostic Int. (San
Antonio, TX, USA) consisting of: (i) rabbit polyclonal anti-rat AQP 3, directed against a
15-amino-acid sequence from the C terminus of rat AQP 3 and (ii) rabbit polyclonal antirat AQP 9, raised against a 19-amino-acid synthetic peptide from the rat AQP 9 Cterminal domain. The antisera were employed at a dilution of 1:100 in combination with a
goat anti-rabbit whole secondary antibody (Jackson ImmunoResearch, West Grove, PA,
USA). Each antibody has been extensively characterized in western blot and
immunolocalization studies on mouse and rat tissues, and established as specific for their
target proteins (Ishibashi et al., 1994; Ma et al., 1994; Ecelbarger et al., 1995; Echevarria
et al., 1996; Ishibashi et al., 1997; Koyama et al., 1997; Ishibashi et al., 1998 ; Barcroft et
al., 2004).
2.2.9 Indirect Immunofluorescence Detection of AQP 3 and 9
Mouse embryos were collected from the reproductive tracts of superovulated female MF1 mice as described above. Embryo pools were washed in 1x PBS (GIBCO) and fixed for
indirect immunofluorescence in 2% paraformaldehyde in PBS at room temperature for 30
min. Fixed embryos were washed once in 1x PBS and either used immediately or stored
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at 4°C in embryo storage buffer (1x PBS + 0.9% sodium azide) for up to 1 week before
processing for whole-mount indirect immunofluorescence as previously described (Jones
et al., 1997; Betts et al., 1998; MacPhee et al., 2000; Barcroft et al., 2003, 2004). Fixed
embryos were permeabilized in blocking buffer (0.01% Triton X-100 + 5% normal goat
serum in 1x PBS) at room temperature for 30 min followed by two washes in fresh PBS.
Embryos were incubated with primary antibody for AQP 3 or 9 at a 1:100 dilution in
antibody dilution/wash buffer (ADB; 0.005% Triton X-100 + 1% normal goat serum in
1x PBS) at 4°C overnight. Negative controls included embryos incubated in ADB alone
without the addition of the primary antibody in order to determine the levels of nonspecific fluorescence. Embryos were then washed three times for 20 min in ADB at 37°C
and incubated with fluorescein isothiocyanate (FITC)-conjugated secondary antibody
(1:200 in ADB) at 4°C overnight, followed by three washes for 20 min in ADB at 37°C.
Fully processed embryos were mounted onto glass slides in 20 µl of FluoroGuard antifade reagent (BioRad) under elevated 22 x 22 mm glass coverslips (No. 1 thickness), and
slide preparations were sealed with nail polish. Slides were stored for up to 2 days at 4°C
in a light tight box prior to immunofluorescence imaging employing a BioRad MRC600
Confocal Laser Scanning Microscope. In total, 20–30 embryos for each treatment were
examined for each of the two primary antisera.
2.2.10 Hyperosmotic Treatment of Embryos for Apoptosis Assessment
Embryos were collected as described above. They were then placed in KSOMaa or
hyperosmotic sucrose or glycerol media, with or without inhibitors, for 6 h. They were
then washed in fresh 50 µl KSOMaa drops and placed into fresh 20 µl KSOMaa drops
and culture as described above.
2.2.11 TUNEL Apoptosis Assay
Cleavage of genomic DNA during apoptosis yields single strand breaks in high molecular
weight DNA, which can be identified by labeling the free 3'-OH terminal with modified
nucleotides in an enzymatic reaction (Saraste and Pulkki, 2000; Huerta et al., 2007). Once
the blastocyst stage was reached, embryo pools were fixed for 1 h in 2%
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paraformaldehyde in PBS and washed in PBS. Fixed embryos were then permeabilized
and blocked by room temperature incubation for 1 h in permeabilization solution (1%
sodium citrate + 0.01% Triton X-100). The first negative controls did not undergo
permeabilization. The embryos were then placed into a humidified chamber and placed at
4°C for 2 min. They were then washed again in PBS, and a positive control group was
removed from the treatment groups and treated with 100 µl DNAse solution (10 µl
DNAse1 in 990 µl 50 mM Tris-HCl) for 10 min at room temperature. This was done to
induce strand breaks, allowing for the assessment of maximal DNA fragmentation during
analysis. A second group of embryos was removed from the treatment groups to serve as
the second negative control for fixed embryos. Both groups of negative control embryos
were put into 50 µl TUNEL label solution (nucleotide mixture in reaction buffer). The
positive control and the treatment groups were placed in 50 µl TUNEL reaction mixture
(terminal deoxynucleotidyl transferase from calf thymus, recombinant in Escherichia
coli, in storage buffer + nucleotide mixture in reaction buffer). The TUNEL reaction
mixture-labeled DNA strand breaks through terminal deoxynucleotidyl transferase, which
catalyzes polymerization of labeled nucleotides to the free 3'-OH DNA ends in a
template-independent manner, and by incorporating fluorescein labels in nucleotide
polymers (Byrne et al., 1999; Saraste and Pulkki, 2000). The fluorescein label was
detected by epifluorescence microscopy. The two negative controls, the positive control
and the treatment groups were incubated for 60 min in a humidified chamber at 37°C.
Upon removal from the chamber, the groups were washed in 0.5 µl DAPI (4’,6diamidino-2-phenylindole dihydrochloride; Sigma-Aldrich; diluted 1:2000 from 1 mg/ml
stock solution) + 200 µl PBS for 30 min, to stain the DNA within the nuclei. The groups
were washed twice more in 200 µl PBS, leaving 15 min between the washes. Fully
processed embryos were mounted onto glass slides in a drop of FluoroGuardTM anti-fade
reagent (BioRad Laboratories Canada Ltd., Mississauga, ON, Canada). Fluorescence
imaging was conducted on a Zeiss Axiovert 100 inverted microscope equipped with
epifluorescence optics and digital image analysis software (Carl Zeiss Inc., Thornwood,
NY, USA).
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2.2.12 Caspase-3 Assay for Apoptosis
Activated caspase-3 in preimplantation embryos was detected using the PhiPhilux G1D2
kit (OncoImmunin Inc., College Park, MD, USA). 10–15 embryos from each treatment
were incubated with 30 µl caspase-3 substrate under oil for 1 h at 37°C in air with 5%
CO2. After three washes in dilution buffer, embryos were fixed with 2%
paraformaldehyde in PBS for 30 min at 4°C in the dark. After three washes in PBS, the
first of which contained DAPI, fully processed embryos were mounted onto glass slides in
a drop of FluoroGuardTM anti-fade reagent (BioRad). Fluorescence imaging was
conducted on a Zeiss Axiovert 100 inverted microscope equipped with epifluorescence
optics and digital image analysis software (Carl Zeiss Inc.).
2.2.13 Apoptotic Fluorescence Image Analysis
Apoptotic fluorescence was assessed by first counting the number of DAPI-stained (blue)
nuclei, visualized by an excitation wavelength of 450–500 nm, representing the total
number of cells in the early embryo. Then, the FITC-positive (green signal), apoptotic
nuclei were counted, visualized by an excitation wavelength of 515–565 nm. To obtain
the percent of apoptotic cells, the number of FITC-stained cells was divided by the DAPIstained cells. All microscope and image capture settings remained constant during the
digital capture of micrographs between embryos and between treatment groups. Acquired
micrographs were saved in TIFF image format and processed using Adobe Photoshop
CS2 (Adobe Systems Inc., San Jose, CA, USA) for recognition, selection and separation
of the desired chromogen signal. Qualitative analysis was done by separation of the blue
channels (representing DAPI-stained nuclei) and the green channels (representing FITC
fluorescence of fragmented DNA).
2.2.14 Statistical Analysis
Statistical analysis of data was carried out using SPSS®, version 12.0 (SPSS Inc.,
Chicago, IL, USA) software package. TUNEL assay and Caspase-3 assay results are
presented as the mean ± SEM for percent apoptosis from three independent replicates. All
data were tested for homogeneity of variances by independent sample t-tests for equality
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of variances. In instances of equal variance, data were subjected to one-way analysis of
variance (ANOVA), and followed by Tukey’s multiple comparison test. When equal
variances were not observed, data were arcsine-transformed and then subjected to
ANOVA, followed by Tukey’s multiple comparison test. For all data analysis, p≤ 0.05
was considered statistically significant.

2.3 Results
2.3.1 Experimental Design
Our first objective was to define the experimental parameters for treating embryos with
hyperosmotic media. Eight-cell mouse embryos were cultured in normal KSOMaa (265
mOsm), and KSOMaa made hyperosmotic with either sucrose or glycerol to 300 and 350
mOsm. Embryos were cultured for 3, 6 and 24 h and examined and fixed or frozen for
immunofluorescence or real-time RT–PCR. Figure 2.1 shows representative phase
contrast images of embryos cultured under the above described conditions. Embryos
cultured in KSOMaa for 24 h progressed normally to the blastocyst stage. Embryos
cultured in 300 mOsm sucrose medium compacted, but were unable to progress to the
blastocyst stage. Embryos cultured in 350 mOsm sucrose medium were delayed
developmentally and did not compact or proceed to the blastocyst stage. In contrast,
embryos cultured in glycerol hyperosmotic media at both 300 and 350 mOsm compacted
and progressed normally to the blastocyst stage (Figure 2.1).
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Figure 2.1 Culture Stress Affects Blastocyst Formation
Phase contrast images of embryos cultured in hyperosmotic media using sucrose or
glycerol. Phase contrast images of embryos cultured in 265 (normal KSOMaa), 300
(KSOMaa + sucrose or glycerol) or 350 mOsm (KSOMaa + sucrose or glycerol).
Embryos were cultured for 3, 6 or 24 h before development was assessed based on
morphology. Embryos cultured in KSOMaa, KSOMaa + 300 mOsm glycerol and
KSOMaa + 350 mOsm glycerol were all able to develop to the blastocyst stage in normal
proportions. Embryos cultured in 300 mOsm sucrose compacted, but did not cavitate.
Embryos cultured in 350 mOsm did not compact and arrested at the 8–16 cell stage; Scale
bar = 20 microns.
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2.3.2 Aqp 3 mRNA Levels After Hyperosmotic Treatment Using Sucrose or Glycerol
There was no significant difference in Aqp 3 mRNA abundance after 3 h in hyperosmotic
media (data not shown). Aqp 3 expression after 6 h (Figure 2.2A) in 350 mOsm sucrose
media was significantly elevated undergoing a 2.14-fold increase over KSOMaa control
mRNA levels. After 24 h, Aqp 3 (Figure 2.2B) mRNA levels were significantly elevated
by 2.64-fold in 300 mOsm sucrose over control levels, but were not significantly elevated
in embryos cultured in 350 mOsm sucrose. Interestingly, after 6 and 24 h in glycerol
treatment, Aqp 3 mRNA levels were significantly decreased (P >0.05) in embryos
cultured in 350 mOsm glycerol medium (Figure 2.2 C and D). Aqp 3 mRNA levels were
decreased by 80% compared with KSOMaa control levels after 6 h and 60% from
KSOMaa control levels after 24 h in 350 mOsm glycerol hyperosmotic treatment.
2.3.3 Aqp 9 mRNA Levels After Hyperosmotic Treatment Using Sucrose or Glycerol
There was no significant difference in Aqp 9 mRNA abundance after 3 h in hyperosmotic
media (data not shown). Aqp 9 mRNA expression underwent a 1.97-fold increase after 6
h (Figure 2.2 E) in 300 mOsm sucrose media over KSOMaa control levels and a 2.73-fold
increase in 350 mOsm sucrose media over control levels. By 24 h, Aqp 9 mRNA
expression was significantly (P >0.05) increased by 4.3-fold in 300 mOsm sucrose and 8fold in 350 mOsm sucrose over control levels (Figure 2.2 F). Figure 2.2 G and H indicate
that in contrast to the sucrose hyperosmotic treatment results, Aqp 9 mRNA levels were
not significantly increased in any of the glycerol medium treatment groups at either time
point.
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Figure 2.2 Relative Aqp 3 and 9 mRNA Levels Following Treatment.
Real-time RT–PCR was used to determine the relative mRNA levels of Aqp 3 after 6 (A)
or 24 h (B) in sucrose hyperosmotic media. Aqp 3 mRNA was significantly elevated after
(A) 6 h in 350 mOsm and (B) 24 h in 300 mOsm; n = 3, mean ± SE, P ≤ 0.05. Real-time
RT–PCR was used to determine the relative mRNA levels of Aqp 3 following (C) 6 or
(D) 24 h exposure to glycerol hyperosmotic medium treatment. There were no significant
increases in Aqp 3 mRNA levels between glycerol medium treatments and KSOMaa (265
mOsm) control. Real-time RT–PCR was used to determine the relative mRNA levels of
Aqp 9 after 6 (E) or 24 h (F) in sucrose hyperosmotic media. Aqp 9 mRNA was
significantly elevated in embryos cultured for (E) 6 and (F) 24 h in 300 and 350 mOsm
treatment media. In contrast, treatment for (G) 6 and (H) 24 h exposure to glycerol
hyperosmotic medium did not result in a significant change in mRNA levels for Aqp 9
between glycerol medium treatments and KSOMaa (265 mOsm) (G,H).
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Figure 2.3 AQP 3 and 9 Protein Localization Following Treatment with Sucrose or
Glycerol Hyperosmotic Medium.
Representative images of AQP 3 after 6 (A–C) or 24 h (D–F) exposure and AQP 9 after 6
(G–I) or 24 h (J–L). AQP 3 and 9 protein localization pattern varied by 6 (B,C; H,I) and
24 h (E,F; K,L) in sucrose hyperosmotic medium from normal distribution patterns in
KSOMaa (A,D; G,J), showing enhanced cytoplasmic components of normal AQP 3 and 9
localization. Glycerol treatment did not affect AQP 3 and 9 localization compared with
untreated controls. n = 20–30 embryos in each group; scale bar = 20 microns. No primary
antibody negative control (M).
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2.3.4 AQP 3 and 9 Protein Localization After Hyperosmotic Treatment Using
Sucrose or Glycerol
AQP protein localization was next investigated using whole-mount immunofluorescence
for AQP 3 and 9 polypeptides. Figure 2.3 displays representative images of normal
distribution of AQP 3 (Figure 2.3A and D) and 9 (Figure 2.3G and J) and abnormal
distribution of AQP 3 and 9 after exposure to hyperosmotic conditions. These images
represent the range of morphologies observed after exposure to hyperosmotic media.
There were no visible changes in AQP 3 or 9 localization after 3 h in hyperosmotic media
(data not shown). Both polypeptides maintained the cortical, apolar localization patterns
reported by Barcroft et al. (2003). After 6 h, however, AQP 3 localization shifted from
the cortical distribution to become primarily cytoplasmic under 300 and 350 mOsm
sucrose medium conditions (Figure 3B and C). After 24 h in sucrose hyperosmotic media,
the AQP 3 distribution became predominantly cytoplasmic (Figure 3E and F).
Localization of AQP 9 underwent a more dramatic change to become predominantly
cytoplasmic in both 300 and 350 mOsm sucrose medium treatments at 6 h, although some
cortical localization was observed (Figure 3H and I). AQP 9 distribution remained
cytoplasmic in both 300 and 350 mOsm at 24 h, although some cortical expression was
observed (Figure 3K and L). AQP 3 and 9 protein localization was not affected by culture
in glycerol medium in any of the treatment groups or at any time point (data not shown).
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Figure 2.4 Relative Aqp 3 and 9 mRNA Levels Following Treatment in the Presence
of Either a MAPK14/11 or MAPK8 Inhibitor.
Real-time RT–PCR was used to determine the relative mRNA levels of Aqp 3 after (A) 6
or (B) 24 h exposure to sucrose hyperosmotic medium treatment + SB220025 (a
MAPK14/11 inhibitor). No significant increases in Aqp 3 mRNA levels were observed
after (A) 6 h but after (B) 24 h exposure to sucrose hyperosmotic media Aqp 3 mRNA
levels significantly declined in the presence of SB220025. The Aqp mRNA levels of Aqp
9 after (E) 6 or (F) 24 h exposure to sucrose hyperosmotic medium treatment +
SB220025 did not vary significantly between any treatments after (E) 6 or (F) 24 h. The
relative mRNA levels of Aqp 3 were measured after (C) 6 or (D) 24 h exposure to sucrose
hyperosmotic medium treatment + SP600125 (a MAPK8 inhibitor). There was a
significant increase in Aqp 3 mRNA after 6 (C) and 24 h (D) in embryos exposed to 350
mOsm sucrose hyperosmotic medium treatment + SP600125; n = 3, mean ± SE, P ≤ 0.05.
The Aqp 9 mRNA levels after (G) 6 or (H) 24 h exposure to sucrose hyperosmotic
medium treatment + SP600125 were significantly increased compared with control
values; n = 3, mean ± SE, p ≤ 0.05.
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2.3.5 Aqp 3 and 9 mRNA Levels After Hyperosmotic Treatment Using Sucrose in
the Presence of a MAPK14/11 Inhibitor
Our next objective was to define the signaling pathways regulating the sucrose
hyperosmotic treatment induction of AQP mRNA expression. We first examined the
effects of blocking MAPK14/11 on Aqp mRNA levels. To address this, embryos were
cultured in sucrose hyperosmotic media as described above with the addition of 2 µM
SB220025 (Natale et al., 2004). The 3 h time point was not included (nor the glycerol
treatments) in these experiments because Aqp 3 and 9 mRNA expression did not vary
from controls under these conditions. In contrast to what was observed with sucrose
hyperosmotic media alone (Figure 2A), after 6 h of treatment with sucrose media in the
presence of MAPK14/11 inhibitor, we did not detect a significant increase in Aqp 3
mRNA levels (Figure 2.4A) compared with KSOMaa control levels. However, after 24 h,
we observed a significant decrease in the Aqp 3 mRNA levels (Figure 2.4B). In contrast to
what was observed with sucrose hyperosmotic media alone, in the presence of the
MAPK11/14 inhibitor, Aqp 9 mRNA levels did not significantly increase in sucrose
media after 6 (Figure 2.4E) or 24 h (Figure 2.4F) compared with KSOMaa control levels.
AQP 3 and 9 protein localization following sucrose hyperosmotic treatment and
MAPK14/11 inhibitor did not vary from that observed in untreated controls, indicating
that MAPK14/11 blockade negated the transition to a predominantly cytoplasmic
distribution observed following sucrose hyperosmotic medium treatment (data not
shown).
2.3.6 Aqp 3 and 9 mRNA Levels After Hyperosmotic Treatment Using Sucrose in
the Presence of a MAPK8 Inhibitor
We next investigated whether the MAPK8 pathway may also regulate Aqp 3 and 9
mRNAs following exposure to hyperosmotic media. To address this, embryos were
cultured in sucrose hyperosmotic media as described above with the addition of 10 µM
SP600125 (Xie et al., 2006, 2007). The 3 h time point was not included (nor the glycerol
treatments) in these experiments because Aqp 3 and 9 mRNA expression did not vary
from controls under these conditions (see above). After 6 h of treatment with 350 mOsm
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sucrose hyperosmotic medium in the presence of MAPK8 inhibitor, we still observed
significant increases in Aqp 3 (Figure 2.4C) and 9 (Figure 2.4G) mRNA levels compared
with KSOMaa control levels. After 24 h, we also observed significant increases in Aqp 3
(Figure 2.4D) and 9 (Figure 2.4H) mRNA levels in 350 mOsm sucrose hyperosmotic
medium compared with the KSOMaa control. In the presence of a MAPK8 inhibitor,
AQP 3 and 9 protein distribution predominantly consisted of the expected cortical
distribution observed in untreated controls but also included a cytosolic component in the
presence of hyperosmotic media and the MAPK8 blocker (data not shown). These data
suggest that the MAPK8 pathway is not a primary mediator of the variations in level and
expression in AQP 3 and 9 in response to hyperosmotic stress.
2.3.7 Apoptosis in Embryos Cultured in KSOMaa, 300 and 350 mOsm Sucrose or
Glycerol Media
Our results to this point indicate that sucrose hyperosmotic treatment affects AQP mRNA
and protein distribution, and these effects are primarily mediated via the MAPK14/11
pathway and not the MAPK8 pathway. We next investigated whether hyperosmotic
treatment would affect the incidence of cell death or apoptosis. We hypothesized that the
presence of aquaglyceroporins would reduce the incidence of apoptosis in the presence of
glycerol hyperosmotic treatment. Eight-cell mouse embryos were treated with the
respective medium for 6 h and then placed into normal KSOMaa medium for assessment
of apoptosis at the blastocyst stage (24 h in culture total time). Analysis of apoptosis by
TUNEL in blastocysts after 6 h in KSOMaa, 300 or 350 mOsm KSOMaa using glycerol
or sucrose revealed that there was a significant increase (p≤ 0.05) in apoptotic nuclei in
embryos treated with 350 mOsm sucrose medium when compared with normal KSOMaa
or hyperosmotic glycerol medium (Figure 2.5A). Comparison of means by independent
sample t-tests and one-way ANOVA indicated that there was no significant difference in
apoptotic cells between KSOMaa controls, 300 mOsm glycerol, 300 mOsm sucrose and
350 mOsm glycerol-treated groups (Figure 2.5A). To validate this finding further, we also
measured apoptosis using a caspase-3 assay. The caspase-3 assay revealed that embryos
treated for 6 h in 350 mOsm sucrose medium also displayed a significant increase in
apoptosis (p≤ 0.05) when compared with KSOMaa or hyperosmotic glycerol medium.
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Figure 2.5B depicts representative images of TUNEL and caspase-3-labeled apoptotic
cells in embryos cultured for 6 h in KSOMaa and 350 mOsm KSOMaa sucrose
treatments.
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Figure 2.5 Apoptosis Following Hyperosmotic Media Treatment for 6 h.
(A) TUNEL and caspase-3 assays were used to assess the level of apoptosis in blastocysts
after having been exposed to hyperosmotic media for 6 h and then allowed to develop to
the blastocyst stage in normal KSOMaa media. Embryos cultured in glycerol
hyperosmotic media displayed the same level of apoptosis as control embryos cultured in
KSOMaa. Embryos cultured in 350 mOsm sucrose medium displayed a significant
increase in apoptosis compared with controls; mean ± SE, p ≤ 0.05.
(B) Representative images of embryos displaying TUNEL or caspase-3 positive cells; n =
20–30 embryos in each group. Embryos cultured in 350 mOsm sucrose hyperosmotic
medium displayed a greater incidence of apoptotic nuclei than embryos cultured in the
control KSOMaa or 300 mOsm groups; scale bar = 20 microns.
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Figure 2.6 Apoptosis in Hyperosmotic Media-Treated Embryos Plus MAPK14/11
Inhibitor
(A) TUNEL and caspase-3 assays were used to assess apoptosis in blastocysts following
exposure of 8-cell stage embryos to hyperosmotic medium treatment for 6 h in the
presence of SB220025. Blockade of the MAPK14/11 pathway did not affect the
appearance of normal elevated apoptosis levels following exposure to sucrose
hyperosmotic media; mean ± SE, p ≤ 0.05.
(B) Representative images of TUNEL or caspase-3-treated embryos exposed to 350
mOsm hyperosmotic media (sucrose or glycerol) + SB220025 or 350 mOsm
hyperosmotic media (sucrose or glycerol) + SB202474. Embryos cultured in 350 mOsm
sucrose hyperosmotic + SB220025 medium displayed a greater incidence of apoptotic
nuclei than embryos cultured in the control KSOMaa + SB220025 or 350 mOsm glycerol
+ SB220025. There was no significant difference in apoptosis levels between embryos
cultured in the presence of SB220025 or SB202474; scale bar = 20 microns. n = 20–30
embryos in each group.
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2.3.8 Apoptosis Following Culture in KSOMaa and 350 mOsm Sucrose or Glycerol
Medium in the Presence of MAPK14/11 or MAPK 8 Blocker
We next investigated whether inhibition of the MAPK14/11 pathway would affect
apoptosis after embryos were cultured in hyperosmotic medium. Figure 2.6 illustrates that
embryos cultured in the 350 mOsm sucrose medium in the presence of the MAPK14/11
inhibitor displayed similar levels of apoptosis using both the TUNEL and caspase-3
assays as did embryos cultured in the MAPK14/11 inactive analog SB202474 and
DMSO. Figure 2.6 B depicts representative images of TUNEL and caspase-3-labeled
apoptotic cells in embryos cultured for 6 h in KSOMaa, 350 mOsm KSOMaa using
glycerol or sucrose treatments in the presence of SB220025. We next characterized
whether inhibition of the MAPK8 pathway would affect apoptosis following embryo
culture in hyperosmotic medium. Apoptosis was not affected by blocking MAPK8
activity in control (KSOMaa) culture embryos or in embryos cultured in glycerol
treatment media (Figure 2.7). However, for embryos cultured in the 350 mOsm sucrose
treatment medium, blockade of MAPK8 activity resulted in a significant decrease in
apoptosis as assessed by both TUNEL and caspase-3 assays (p ≤ 0.05) (Figure 2.7).
Figure 2.7B depicts representative images of TUNEL and caspase-3-labeled apoptotic
cells in embryos cultured for 6 h in KSOMaa, 300 and 350 mOsm KSOMaa using
glycerol or sucrose treatments.
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Figure 2.7 Apoptosis in Hyperosmotic Media-Treated Embryos Plus MAPK8
Inhibitor.
(A) TUNEL and caspase-3 assays were used to assess apoptosis in blastocysts following
exposure of 8-cell stage embryos to hyperosmotic medium treatment for 6 h in the
presence of SP600125; mean ± SE, p ≤ 0.05. MAPK8 pathway inhibition completely
blocked apoptosis following treatment with 350 mOsm sucrose hyperosmotic media.
(B) Representative images of TUNEL or caspase-3-treated embryos exposed to 350
mOsm hyperosmotic media (sucrose or glycerol) + SP600125 or 350 mOsm
hyperosmotic media (sucrose or glycerol) + MAPK8 inactive inhibitor. Embryos cultured
in 350 mOsm sucrose hyperosmotic + SP600125 medium displayed no incidence of
apoptotic nuclei compared with embryos cultured in the control KSOMaa + SP600125 or
350 mOsm glycerol + SP600125. There was a significant difference in apoptosis levels
between embryos cultured in the presence 350 mOsm sucrose hyperosmotic + SP600125
and embryos cultured in 350 mOsm sucrose hyperosmotic + MAPK8 inactive inhibitor;
scale bar = 20 microns. n = 20–30 embryos in each group.
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2.4 Discussion
In this study, we have demonstrated that preimplantation embryos may be cultured at
physiological osmolarities if the culture medium is supplemented with glycerol instead of
sucrose. In addition, AQP 3 and 9 gene expression and protein localization are regulated
by osmotic treatment, indicating that AQPs are important components of the adaptive
mechanisms that preimplantation embryos employ in response to a changing
environment. Interestingly, Aqp 3 and 9 mRNA levels and protein distribution were only
affected by sucrose treatment and not by glycerol treatment, indicating that AQP 3 and 9
function to alleviate cellular stress imposed by the external environment. This conclusion
was validated by our observations that glycerol treatment did not result in elevated
apoptosis, unlike the sucrose treatment. Thus, AQP 3 and 9 also participate in regulating
apoptosis by reducing cellular stress. Furthermore, we have demonstrated by the use of
specific and potent MAPK inhibitors that the regulation of AQP expression and
localization primarily occurs by the MAPK14/11 pathway, whereas apoptosis is primarily
regulated by the MAPK8 pathway. Taken together, these outcomes support the overall
conclusion that AQP 3 and 9 function in part to alleviate cellular osmotic stress and
indicate that the MAPK14/11 and MAPK8 pathways are important stress-activated
pathways that have distinct roles to play in regulating embryonic responses to stress.
AQPs act as water channels, allowing water and solutes to cross the plasma membrane in
the absence of a steep osmotic gradient. Their physiological role has been defined as
regulating near iso-osmotic water transport (Ishibashi et al., 2000; Agre and Kozono,
2003; Barcroft et al., 2003; Agre, 2006). Exposure to hyperosmotic conditions would
increase the ionic gradient across the plasma membrane and this may provide a stimulus
for enhanced expression of AQPs in an attempt to alleviate the stress. The shift in AQP
protein distribution from a primarily cortical to a cytoplasmic distribution may reflect the
progression of newly synthesized protein en route to the plasma membrane. This finding
would be consistent with our prediction that the alterations in AQP expression that occur
following exposure to hyperosmotic medium reflect an adaptive cellular response to
culture-induced stress.
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The MAPK14/11 pathway is activated in response to hyperosmotic treatment in the
embryo and in other cell types (Arima et al., 2003; Fong et al., 2007). In addition, MAPK
signaling is implicated in the regulation of AQP 3 and 9 (Arima et al., 2003; Cao et al.,
2006) and other AQPs (Hoffert et al., 2000; Umenishi and Schrier, 2003; Hansen and
Galtung, 2007). These studies noted, however, that the total protein levels for the MAPK
pathway did not increase in response to hyperosmotic stress and that signaling occurred
via increased phosphorylation of the MAPK pathway constituents. Our results certainly
support the conclusion that the hyperosmotic treatment-induced influences on AQP
expression and distribution are primarily regulated by MAPK14/11 in the preimplantation
embryo. Of interest, embryos cultured in normal KSOMaa + MAPK14/11 inhibitor did
not show any changes in Aqp 3 and 9 mRNA expression or protein localization.
Therefore, MAPK14/11 regulation of AQP 3 and 9 may be primarily directed during
responses to hyperosmotic stress and is not a component of the normal regulatory
mechanisms controlling basal AQP expression during preimplantation development.
In complete contrast to the results obtained following sucrose hyperosmotic treatment,
embryos cultured in 350 mOsm glycerol hyperosmotic medium were morphologically
identical to embryos cultured in KSOMaa. As well, they did not demonstrate any changes
in mRNA expression or protein localization for Aqp 9. We did, however, observe a
decrease in the mRNA expression of AQP 3 after 6 and 24 h in embryos treated with
hyperosmotic glycerol media. This could be indicative of the embryo attempting to
regulate the accumulation of glycerol within the blastomeres by decreasing the expression
of an aquaglyceroporin such as AQP 3. This result would indicate that Aqp 3 mRNA is
responsive but Aqp 9 mRNA is not, demonstrating that these AQPs are differentially
regulated and can respond independently to environmental changes that the embryo
experiences. Offenberg et al. (2005) examined the expression of Aqp 3 and Aqp 9 in
blastocysts cultured from the 8-cell compacted embryo in hyperosmotic conditions for 40
h and did not report any changes in mRNA levels. Our studies examined effects over a
much shorter time period (3, 6 and 24 h). We predict that our results and those of
Offenberg et al. (2005) suggest that the influences on AQP expression occur fairly rapidly
following exposure to hyperosmotic medium and then may return to basal levels by 40 h
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after exposure to hyperosmotic medium. Offenberg et al. (2005) did, however, show
increases in Aqp 3 and 9 mRNA expression after blastocyst puncture, which supports our
observation that AQP 3 and 9 expression is regulated under stressful conditions.
The ability of treated embryos to progress in normal numbers to the blastocyst stage in
the 350 mOsm glycerol medium is intriguing. We would propose that this occurrence is
due in part to the presence of AQP 3 and 9 and their role as aquaglyceroporins to promote
the movement of glycerol into the cell down the glycerol concentration gradient (Zelenina
et al., 2004; Hara-Chikuma and Verkman, 2005; Karlgren et al., 2005; Hara-Chikuma and
Verkman, 2006; Liu et al., 2007; Rojek et al., 2007). The presence of AQP 3 and 9 could
alleviate the osmotic gradient, establishing equilibrium with the external medium and thus
eliminating the presence of osmotic stress on the embryo in the 350 mOsm glycerol
medium. Barcroft et al. (2003) demonstrated that AQPs were present and functional in
the preimplantation embryo by exposing blastocysts to an 1800 mOsm glycerol solution.
Under these conditions, the blastocysts initially collapse but then recover completely
within 3 min to restore their original shape and volume (Barcroft et al., 2003). In this
example, normal expression of aquaglyceroporins allowed the embryos to transport
glycerol across the blastocyst membrane quickly and restore normal blastocyst volume,
however, when the same experiment was conducted using sucrose instead of glycerol,
embryos were not able to regain their expanded form (Barcroft et al., 2003). In
conclusion, our outcomes would suggest that culture in 350 mOsm glycerol medium does
not impair development to the blastocyst stage in vitro, does not activate the MAPK14/11
pathway or alter AQP expression, thus it does not appear to evoke a cellular stress
response.
Apoptosis is an important mechanism linked to the cellular response to stress (Kurzawa et
al., 2002; Esfandiari et al., 2005; Zander et al., 2006; Esfandiari et al., 2007; Oh et al.,
2007; Xie et al., 2007). Apoptotic mechanisms are well defined during preimplantation
development, and this developmental event is normally first observed at the blastocyst
stage (Pierce et al., 1989; Hardy, 1997, 1999; Warner et al., 1998; Byrne et al., 1999;
Huppertz et al., 1999; Pampfer, 2000; Levy et al., 2001). Both MAPK14/11 and MAPK8
pathways mediate cellular apoptosis and it is for this reason that we investigated the
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effects of exposure to hyperosmotic medium treatment on apoptosis. Our results indicate
that hyperosmotic stress using sucrose treatment will increase the levels of apoptosis.
However, 350 mOsm glycerol medium does not elicit a similar apoptotic response. Xie et
al. (2007) demonstrated that the MAPK8 pathway regulates apoptosis during
preimplantation development. Interestingly, our results support those of Xie et al. (2007)
and suggest that the MAPK8 pathway is the primary mediator of osmotic stress-induced
apoptosis. Our outcomes support our assertion that the exposure to glycerol hyperosmotic
medium does not elicit a cellular stress response due to the action of AQP 3 and 9, which
alleviate the osmotic stress by allowing glycerol to cross the cell membrane. Thus, AQP 3
and 9 may also function to regulate the occurrence of apoptosis in cell systems. Clearly,
blockade of the MAPK14/11 pathway had no effect on hyperosmotic treatment-induced
apoptosis, whereas blockade of the MAPK8 pathway completely negated the increased
apoptosis observed following treatment with hyperosmotic sucrose medium. Treatment
with either the MAPK14/11 or MAPK8 inhibitor applied to normal KSOMaa media
control embryos had no effect on reducing embryonic apoptotic levels, indicating that
basal apoptotic levels are unlikely to be under the control of either pathway. Thus, our
experiments have also shed light on the roles of two MAPK pathways, MAPK14/11 and
MAPK8 in regulating apoptosis, and also their roles in response to embryonic exposure to
hyperosmotic treatment. Each pathway has a distinct but important contribution to the
mechanisms controlling preimplantation development.
We therefore conclude that the changes in Aqp 3 and 9 mRNA levels and protein
distribution are the components of a rapid adaptive response that the embryo employs to
alleviate cellular stress. The sucrose treatment exceeds the adaptive capacity of the
preimplantation embryo, resulting in the activation of apoptosis and induced cell death.
MAPK14/11 activation is therefore, in this context, a component of the rapid adaptive
stress response mechanism, whereas the MAPK8 pathway regulates apoptosis. Our results
indicate that culture in 350 mOsm KSOMaa + glycerol medium is not detrimental for
preimplantation development and this may allow early embryo culture at more
physiological osmolarities. These outcomes improve our understanding of the embryonic
adaptive mechanisms to environmental stress and indicate that AQPs are critical

92
components of the embryo's response to stressful environments. They may also lead to
further developments in the optimization of culture media for the production of
mammalian preimplantation embryos in vitro.
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3.1 Introduction
Mammalian preimplantation development extends from fertilization to implantation and
culminates in the formation of a blastocyst, a fluid filled structure that emerges from the
zona pellucida and implants into the uterine wall to maintain pregnancy (Watson et al.,
2004; Bell et al., 2008). The early blastocyst consists of two cell types, the inner cell
mass (ICM) and the trophectoderm (TE) (Watson et al., 2004; Bell et al., 2008). The
ICM is an undifferentiated mass of cells that will become the embryo proper. The TE is a
polarized epithelial cell layer which surrounds the ICM. The TE mediates implantation
to the uterine wall, contributes to the embryonic portion of the placenta and is
characterized by the expression of transcription factors (TF), such as caudal homeobox
two (Cdx2) (Strumpf et al., 2005). Functional adherens junctions (AJ) and tight junctions
(TJ) form a seal between the cells of the TE, which is essential for fluid accumulation and
formation of the blastocyst cavity (McLaren et al., 1977; Fleming et al., 1989; Fleming et
al., 1993; Kim et al., 2004; Violette et al., 2006; Hartsock et al., 2007; Niessen, 2007;
Bell et al., 2008; Giannatselis et al., 2011).
The Na/K ATPase is also a critical mediator of blastocyst formation as it establishes a
trans-trophectoderm osmotic gradient that directs fluid movement across the TE
epithelium (Watson et al., 1990; Baltz et al., 1997; Betts et al., 1998; MacPhee et al.,
2000; Kidder et al., 2005; Madan et al., 2007). The Na/K ATPase is comprised of two
main subunits; the alpha (ATP1A) and the beta (ATP1B).

Loss of Atp1a during

preimplantation development does not impede the initial formation of a blastocyst, but
shortly after results in an embryonic lethality during peri-implantation development
(Barcroft et al., 2003). In contrast, loss of Atp1b1 results in a developmental arrest at the
morula stage, and blastocyst expansion does not occur (Madan et al., 2006).
Additionally, the Na/K ATPase acts as an ouabain mediated signaling molecule that
regulates TJ formation and function in the TE (Violette et al., 2006; Giannatselis et al.,
2011). Fluid movement across the TE is facilitated by the presence of aquaporins (AQP)
3 and AQP 9 in the TE membrane (Barcroft et al., 2003). AQP 9 is localized to the apical
surface of the TE and AQP 3 is localized to the baso-lateral surface of the TE, and
together they facilitate fluid movement from the ‘outside’ to the ‘inside’ of the blastocyst
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cavity, along the osmotic gradient maintained by the Na/K ATPase (Barcroft et al., 2003).
Together, the AJs, TJs, Na/K ATPase and AQPs, are critical gene products that
coordinate blastocyst expansion and blastocyst cavity formation (reviewed in Bell et al.,
2008). Although the cell biology of blastocyst formation is well documented, the
molecular signaling events, particularly the intracellular signaling events, governing
blastocyst formation are unclear (reviewed in Yamanaka et al., 2006; Bell et al., 2008).
The p38 MAPK pathway is an intracellular signaling pathway that translates extracellular
stimuli into cellular responses (Cargnello et al., 2011). This intracellular signaling
pathway directs a wide variety of physiological processes through Serine/Threonine
phosphorylation (Cargnello et al., 2011). p38 MAPK is ubiquitously expressed in all
eukaryotic cells and regulates gene expression, mitosis, metabolism, motility, survival,
apoptosis and differentiation (Natale et al., 2004; Wada et al., 2004; Zohn et al., 2006;
Bell et al., 2009; Cargnello et al., 2011). Each component of the p38 MAPK pathway is
present throughout preimplantation development and the p38 MAPK pathway plays both
developmental and adaptive roles during preimplantation development (Natale et al.,
2004; Paliga et al., 2005; Fong et al., 2007; Bell et al., 2009). Our previous studies have
demonstrated that p38 MAPK is both an important mediator of early preimplantation
development and is also a component of the adaptive mechanism the embryo can employ
to adjust to environmental influences during development (Natale et al., 2004; Paliga et
al., 2005; Fong et al., 2007; Bell et al., 2009). P38 MAPK is a gene family consisting of
four different isoforms,

and

Reviewed in Cargnello & Roux, 2011) Our

previous studies focusing on the role of p38 MAPK during preimplantation development
demonstrated that treatment of 2-, 4- and uncompacted 8-cell embryos with the cytokine
suppressive anti-inflammatory drugs (CSAIDsTM; SB203580 and SB220025 active
forms; SB202474 inactive form control) all result in a reversible developmental blockade
that suspends development at the 8-16 cell stage (Natale et al., 2004; Paliga et al., 2005).
CSAIDsTM, SB203580 and SB220025, are potent and specific pharmacological agents
that are routinely and reliably used to investigate p38 MAPK function in cell systems
(reviewed in Jackson et al., 1998; Cargnello & Roux et al., 2011). We also demonstrated
that the p38 MAPK inhibited blockade is accompanied by a downstream loss of
MAPKAPK2/3 phosphorylation, then loss of HSP25/27 phosphorylation and finally a
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disassembly of filamentous actin (Natale et al., 2004; Paliga et al., 2005). 8-16 cell stage
drug free embryos resume their developmental program and progress normally to the
blastocyst stage following treatment with an accompanying delay consistent with the
original CSAID treatment time (Natale et al., 2004; Paliga et al., 2005).
In addition, the p38 MAPK pathway directs preimplantation embryonic responses to
environmental stress (Fong et al., 2007; Bell et al., 2009). Fong et al., 2007 reported that
MAPKAPK2, a downstream target of p38 MAPK, displayed enhanced phosphorylation
in embryos exposed to hyperosmotic culture medium. This elevation in MAPKAPK2
phosphorylation was extinguished when the embryos were cultured under hyperosmotic
conditions in the presence of SB 220025, demonstrating that p38 MAPK was activated in
response to hyperosmotic stress (Fong et al., 2007). Bell et al., 2009 demonstrated that
the p38 MAPK pathway up-regulated Aqp3 and Aqp9 mRNA expression in response to
hyperosmotic stress in 8-cell embryos but did not regulate blastocyst apoptosis levels
resulting from hyperosmotic stress (Bell et al., 2009). Taken together, these results
demonstrate that p38 MAPK signaling regulates both the developmental program of
preimplantation development and embryonic adaptations to environmental stress.
The present study was conducted to investigate the role of p38 MAPK in regulating
cavitation and blastocyst formation. Embryos were cultured from the early blastocyst
stage for 12 h or 24 h in the presence of a p38 MAPK inhibitor, SB 220025. Blastocyst
expansion, zona hatching, TE formation and function, and apoptosis levels were assessed.
We have demonstrated that the p38 MAPK pathway is required for blastocyst expansion
and hatching and for regulating TJ function. Furthermore, suppression of p38 MAPK
signaling resulted in a significant increase in apoptosis levels. These results demonstrate
that p38 MAPK also exerts its influences on blastocyst formation and suggests that it is
an important mediator of blastocyst formation gene family expression, function and thus
coordination of the overall events that regulate blastocyst formation.
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3.2 Materials and Methods
3.2.1 Ovulation Induction and Mouse Embryo Collection

Female MF-1 mice (Charles River, Canada; 3–5 weeks old) were injected with 5 IU
Pregnant Mare’s Serum Gonadotropin (PMSG)(Intervet Canada Ltd, Whitby, Ontario,
Canada), followed by 5 IU human Chorionic Gonadotropin (hCG) (Intervet) 48 h later
and mated with CD-1 males. Successful mating was determined the following morning
(Day 1) by the detection of a vaginal plug. Time post-hCG was used to measure the
developmental stage of the embryos. Preimplantation mouse embryos were flushed from
the reproductive tract using M2 flushing media (Sigma, St Louis, MO, USA) at 89 h
(early blastocyst) post-hCG.

3.2.2 Embryo Culture and Treatment

3.2.2.1 Concentration Response Experiments:
Embryos were washed four to five times in 50 µl drops of either potassium simplex
optimized medium with amino acids (KSOMaa, Chemicon, Temecula, CA, USA) + 0.2%
dimethylsulfoxide (DMSO), KSOMaa + 20 µM SB 202474 (inactive analogue control),
KSOMaa + 2 µM SB 220025, KSOMaa + 5 µM SB 220025, KSOMaa + 10 µM SB
220025 or KSOMaa + 20 µM SB 220025 and transferred to 20 µl drops of the respective
treatment under light paraffin oil. They were maintained in culture under 5% CO2 in air
atmosphere at 37ºC for 24 h. Embryos were imaged at 4 h, 8 h, 12 h and 24 h post
collection. After 12 h or 24 h of treatment, embryos from each group were washed in
fresh KSOMaa (minimum of 3 times) and placed in fresh KSOMaa 20 µl culture drops
for recovery experiments. Embryos were imaged at time points equivalent to 24 h, 28 h
and 36 h post embryo collection. These time points are equivalent to 12 h, 16 h and 24 h
of recovery for 12 h treated embryos and 4 h and 12 h recovery for 24 h treated embryos
respectively (Appendix A: Supplemental Figure 2). Embryo diameter was used to assess
blastocyst expansion.

Diameter of each blastocyst was measured in two different

directions (using Image Pro analysis 6.2 software; Appendix A: Supplemental Figure 1)
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and then averaged and the volume was calculated based on the calculated radius. To
confirm expansion results from embryos treated with SB 220025, embryos were also
treated with 5 µM SB 203580, another potent p38 inhibitor, for 24 h and measured.
Animal care and treatment followed protocols established by the UWO animal care
committee conforming to the Canadian Council for Animal Care (CCAC) guidelines.

3.2.2.2 Assessment of Zona Hatching In Vitro

Embryos were washed four to five times in 50 µl drops of treatment and transferred to 20
µl drops of the respective treatment under light paraffin oil. They were maintained in
culture under 5% CO2 in air atmosphere at 37ºC for 12 h or 24 h. Embryo hatching was
assessed at 24 h and 48 h post collection. An embryo was consider to be “hatching” if
any part of the embryo protruded from the zona pellucida or “hatched” if the embryo was
completely free of the zona pellucida. Four replicates were performed.

3.2.3 Quantitative RT-PCR
Quantitative RT-PCR was conducted to determine the effects of p38 MAPK inhibition on
the mRNA levels of TE associated proteins. Total RNA was extracted from pools of 20
embryos using the PicoPure kit (Arcturus, Molecular Device, Sunnyvale, CA). Reverse
Transcription (RT) reaction was carried out using Sensiscript reverse transcriptase
(Qiagen, Mississauga, ON). The samples were incubated in 10x buffer, RNAse inhibitor,
dNTPs and random primers at 37°C for 1 h. Quantitative PCR reactions were performed
using the BioRad Chromo4 detection system (BioRad, Mississauga, ON). PCR was
carried out in 20 µl reactions containing 10 µl SYBR Green (Invitrogen, Burlington,
ON), 0.2 µl of primer sets provided by Biosearch Technologies (Novado, CA), 1 µl of
appropriate dilution of cDNA (1 embryo/µl), and 8.8 µl of water. To confirm the
specificity of each quantitative RT-PCR product, amplicons were extracted from gels and
purified using a QIAquick gel extraction kit (Qiagen, Mississauga, ON) and submitted for
nucleotide sequencing (DNA Sequencing Facility, Robarts Research Institute, London,
ON, Canada). The nucleotide sequences were then compared with sequences available in
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GenBankTM nucleotide sequence data base, and in all cases the specificity of each PCR
product was confirmed. Aqp3 and Aqp9 were obtained from Applied Biosystems
(Aqp3Assay ID: mm01208559_m1; Aqp 9 Assay ID: mm00508094_m1). All other sequences
can be found in Appendix A: Supplemental Figure 7. Three to six replicates were
performed.
3.2.4 Antisera
Antibodies used in whole mount immunofluorescence procedures were obtained from
commercial sources: CDH1 and TJP1 (Upstate Cell Signaling Solutions, Charlottesville,
VA), CDX2 (Aviva Systems Biology, San Diego, CA), AQP3 and 9 (Alpha Diagnostic
Int. (San Antonio, TX, USA)), ERK and p-ERK (Cell Signalling Technologies (Danvers,
MA, USA).
3.2.5 Indirect Immunofluorescence
Mouse embryos were collected from the reproductive tracts of super ovulated female MF1 mice as described above. Embryo pools were washed in 1x PBS (GIBCO) and fixed for
indirect immunofluorescence in 2% paraformaldehyde in PBS at room temperature for 30
minutes. Fixed embryos were washed once in 1x PBS and either used immediately or
stored at 4°C in embryo storage buffer (1x PBS + 0.1% sodium azide) for up to 1 week
before processing for whole-mount indirect immunofluorescence as previously described
(Betts et al., 1998; MacPhee et al., 2000; Barcroft et al., 2004; Fong et al., 2007; Madan
et al., 2007). Fixed embryos were permeabilized in blocking buffer (0.01% Triton X-100
+ 5% normal donkey serum in 1x PBS) at room temperature for 1 h followed by two
washes in fresh PBS. Embryos were incubated with primary antibody in a 1:100 dilution
in antibody dilution/wash buffer (ADB; 0.005% Triton X-100 + 0.5% normal donkey
serum in 1x PBS) at 4°C overnight. Negative controls included embryos incubated in
ADB alone without the addition of the primary antibody in order to determine the levels
of non-specific fluorescence. Embryos were then washed three times for 30 minutes in
ADB at 37°C and incubated with fluorescein isothiocyanate (FITC)-conjugated secondary
antibody (1:200 in ADB) at 4°C overnight, followed by three washes for 30 minutes in
ADB at 37°C. 4',6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich; diluted 1:2000 from
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1 mg/ml stock solution), a nuclear stain, along with Rhodamine phalloidin (diluted 1:20
into ADB), a filamentous actin (F-actin) stain, were added to the first wash step. Fully
processed embryos were mounted onto glass slides in 20 µl of Vectashield mounting
medium (Vector, Burlingame, CA) under elevated 22 x 22 mm glass cover slips (No. 1
thickness), and slide preparations were sealed with nail polish. Slides were stored for up
to 2 days at 4°C in a light tight box prior to immunofluorescence imaging. Embryos were
examined by confocal microscopy using an Olympus Fluoview 1000 laser scanning
Confocal Microscope (Olympus, Canada). In total, 10-15 embryos for each treatment
were examined for each of the primary antisera.
3.2.6 Assessment of TJ Function by FITC-Dextran Uptake Assay
To investigate the effects of p38 MAPK inhibition on TJ permeability, embryos were
cultured for 12 h or 24 h in KSOMaa, SB 202474, SB 220025 or for 30 minutes in 2 mM
EGTA (ethylene glycol Bis- (β-aminoethyl ether) N,N,N,N -tetraacetic acid).

After

treatment, blastocysts were cultured in drops containing 40 kDa FITC-Dextran in
KSOMaa for 30 minutes. Following this incubation, blastocysts were immediately
washed in three 50 µL wash drops of KSOMaa and placed in a fourth clean KSOMaa
drop for immediate assessment of FITC-dextran accumulation employing an epifluorescent microscope (Olympus). Three replicates were performed for each time point.
3.2.7 TUNEL Apoptosis Assay
Cleavage of genomic DNA during apoptosis yields single strand breaks in high molecular
weight DNA, which can be identified by labeling the free 3'-OH terminal with modified
nucleotides in an enzymatic reaction (Saraste & Pulkki, 2000; Huerta et al., 2007). After
24 h of treatment, embryo pools were fixed for 1 h in 2% paraformaldehyde in PBS and
washed in PBS. Fixed embryos were then permeabilized and blocked for 3 minutes in
permeabilization solution (1% sodium citrate + 0.01% Triton X-100) at 4°C. Embryos
were then washed in PBS, and a positive control group was removed from the treatment
groups and treated with 100 µl DNAse solution (10 µl DNAse1 (Invitrogen) in 990 µl 50
mM Tris-HCl) for 13 minutes at room temperature. This was done to induce strand
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breaks, allowing for the assessment of maximal DNA fragmentation during analysis. A
group of embryos was removed from the treatment groups to serve as the negative control
group. The positive control and the treatment groups were placed in 50 µl TUNEL
reaction mixture (terminal deoxynucleotidyl transferase from calf thymus, recombinant in
Escherichia coli, in storage buffer + nucleotide mixture in reaction buffer). The TUNEL
reaction mixture labeled DNA strand breaks through terminal deoxynucleotidyl
transferase, which catalyzes polymerization of labeled nucleotides to the free 3'-OH DNA
ends in a template-independent manner, and by incorporating fluorescein labels in
nucleotide polymers (Byrne et al., 1999; Saraste & Pulkki, 2000). Negative control
embryos were put into 50 µl TUNEL label solution (nucleotide mixture in reaction
buffer) only. Embryos were incubated for 60 minutes in a humidified chamber at 37°C.
The groups were then washed in 0.5 µl DAPI (Sigma-Aldrich; diluted 1:2000 from 1
mg/ml stock solution) + 200 µl PBS for 30 minutes, to stain the DNA. The groups were
washed twice more in 200 µl PBS, for 15 minutes at 37°C. Fully processed embryos were
mounted onto glass slides in a drop of Vectashield mounting medium. Three replicates
were performed for each time point.
3.2.8 Apoptotic Fluorescence Image Analysis
Embryos were examined by confocal microscopy using an Olympus Fluoview 1000 laser
scanning Confocal Microscope (Olympus, Canada). Z-stack images were taken of the
embryos and used to count total cell number and FITC positive cell number. Apoptotic
fluorescence was assessed by first counting the number of DAPI-stained (blue) nuclei,
representing the total number of cells in the early embryo followed by counting the FITCstained (green) apoptotic nuclei. To obtain the percent of apoptotic cells, the number of
FITC-stained cells was divided by the number of DAPI-stained cells. All microscope and
image capture settings remained constant during the digital capture of micrographs
between embryos and between treatment groups. 10-15 embryos were assessed for each
treatment group.

107
3.2.9 Statistical Analysis

The results from the concentration response and recovery experiments were first
subjected to Normality tests and once passed analyzed by a repeated measure ANOVA
test followed by a Student-Newman-Keuls post hoc test.

All other experiments were

also first subjected to Normality tests and once passed analyzed a one-way ANOVA test
followed by a Student-Newman-Keuls post hoc test. All error bars represent standard
error mean (SEM). Significant p value ≤ 0.05. Data was analyzed using the SigmaStat®
3.5 (Jandel Scientific Software, San Rafael, CA, USA).

3.3 Results
3.3.1 p38 MAPK Regulation of Blastocyst Expansion is SB 220025 Concentration
Dependent
We first defined the concentration and time course effects of treating early blastocysts
with the p38 MAPK inhibitor SB 220025 (Figure 3.1). Embryos cultured in all tested
concentrations of SB 220025 did not display a significant difference from control
embryos following 4 h and 8 h of treatment (data not shown). After 12 h of treatment,
embryos cultured in 5 µM SB 220025 (volume, 494875 ± 44778 microns3), 10 µM SB
220025 (516938 ± 21180 microns3) or 20 µM SB 220025 (505363 ± 23317) displayed a
significant reduction in blastocyst cavity expansion compared to control groups:
KSOMaa + 0.2 % DMSO (712395 ±46015 microns3), KSOMaa + 20 µM SB 202474
(inactive analogue of SB 220025) (638006 ± 84041 microns3). After 24 h of culture,
embryos cultured in 2 µM SB 220025 (617718 ± 69820 microns3), 5 µM SB 220025
(601282 ± 40766 microns3), 10 µM SB 220025 (547158 ± 71035 microns3) or 20 µM
SB 220025 (425879 ± 23317 microns3) all displayed a significant reduction in blastocyst
volume compared to control groups: KSOMaa + 0.2 % DMSO (811406 ± 31382
microns3), KSOMaa + 20 µM SB 202474 (1100180 ± 28571 microns3) (Figure 3.1;
Appendix A: Supplemental Figure 3). From this data, we selected 5 µM SB 220025 as
the lowest effective concentration for investigating the effects of p38 MAPK inhibition
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on blastocyst formation and used this concentration in all subsequent experiments. To
validate the specificity and reproducibility of these outcomes, we repeated this
experiment using a second p38 MAPK inhibitor, SB 203580. Our outcomes employing 5
µM SB 203580 for 24 h were identical to the SB 220025 outcomes in that we observed a
significant reduction in blastocyst volume in the presence of SB 203580 (Appendix A:
Supplemental Figure 5).

To ensure the effects we were observing were not being

mediated by inadvertently affecting the ERK MAPK pathway, we probed embryos
treated for 24 h with 5 µM SB 220025 for total-ERK and phospho-ERK levels by
immunofluorescence. Treatment with SB 220025 had no observable influence on total or
phospho-ERK fluorescence levels (Appendix A: Supplemental Figure 6).
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Figure 3.1 SB220025 Concentration Response and Blastocyst Expansion
Embryos were cultured for 24 h in control media (KSOMaa and SB 202474) or in
KSOMaa + increasing doses of SB 220025 (2 µM, 5 µM, 10 µM and 20 µM) and imaged
at 0 h, 12 h, and 24 h of treatment. The diameter of each embryo was measured as
described in Appendix A: Supplemental Figure 1 and volume was calculated from the
radius. After 12 h and 24 h embryos cultured in KSOMaa + SB 220025 were significantly
less expanded than controls. Three replicates were performed and 30-35 embryos were
measured in each group. SEM p≤0.05
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3.3.2 Embryo Recovery After p38 MAPK Inhibition
After 12 h and 24 h of treatment, embryos were washed extensively in fresh, drug free
medium and then placed into fresh culture drops for a treatment recovery period.
Embryos treated for 12 h and then placed into recovery medium remained significantly
less expanded than controls, however, they did resume expansion and continued to
expand for the full recovery period (Figure 3.2A). Embryos treated for 24 h with SB
220025 did not resume blastocyst expansion following this treatment (Figure 3.2B).

3.3.3 p38 MAPK Activity is Required for In Vitro Zona Hatching
As we established that p38 MAPK signaling regulates blastocyst expansion, we next
investigated the role of p38 MAPK signaling in blastocyst hatching in vitro. Zona
hatching was assessed at 24 h and 48 h post collection. Blastocysts treated for 12 h with
SB 220025 blocked zona hatching (4% ± 4%) compared to KSOMaa (20% ± 15%) and
SB 202474 (24% ± 10%) controls at 24 h post collection. Blastocysts treated for 24 h
with SB 220025 (0%) displayed a significant (p ≤ 0.05) reduction in zona hatching
compared to controls; KSOMaa (22% ± 12%) or SB 202474 (31% ± 10%) (Figure 3.3).
Extending the experimental period to 48 h post collection (i.e. 12 h or 24 h treatment
followed by 36 h or 24 h recovery respectively), had no benefit as embryos treated with
SB 220025 remained enclosed by the zona pellucida (data not shown).
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Figure 3.2 Embryo Recovery After 12 h (A) and 24 h (B) of Treatment
Embryos were washed in fresh KSOMaa after 12 h (A) and allowed to recover until 24 h,
28 h, and 36 h post collection. The diameter of each embryo was measured as described
in Appendix A: Supplemental Figure 1 and volume was calculated from the radius.
(A)

Embryos treated with SB 220025 for 12 h remained significantly less expanded

compared to controls, however, they were still able to expand.
(B)

Embryos treated with SB 220025 for 24 h remained significantly less expanded

compared to controls, and were not able to expand.
Three replicates were performed and 30-35 embryos were measured in each group. SEM
p≤0.05
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Figure 3.3 Inhibition of the p38 MAPK Pathway Prevents Embryo Hatching
(A) Embryos were cultured in KSOMaa, SB 202474 or SB 220025 for 12 h and then
washed in fresh KSOMaa and cultured until 24 h post collection (12 additional
hours) and then assessed for hatching.
(B) Embryos were cultured in KSOMaa, SB 202474 or SB 220025 for 24 h and then
assessed for hatching.
Embryos that had begun to hatch were counted as positive. (SEM; p≤ 0.05; n=4)
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3.3.4 p38 MAPK Signaling, TE Differentiation, AJs and TJs
We next investigated whether TE differentiation or polarization was affected due to p38
MAPK inhibition after 24 h of treatment. To assess TE differentiation, we investigated
the expression of CDX2, a TF that is required for TE linage specification (Strumpf et al.,
2005). CDX2 localization was maintained and confined to the outer cells (yellow arrows)
of both control (KSOMaa Figure 3.4A; SB 202474 Figure 3.4B) and SB 220025 treated
blastocysts (Figure 3.4C).

To investigate TE polarization, we characterized the

localization of CDH1, which is localized to the basolateral membranes of the TE
(reviewed in Yamanaka et al., 2006; Bell et al., 2008). CDH1 displayed a normal
basolateral cell margin distribution pattern in the TE cells in each treatment group (Figure
3.5). We next investigated effects of SB 220025 treatment on TJ permeability using a
standard FITC-dextran assay (Violette et al., 2006; Giannatselis et al., 2011). Blastocyst
expansion is dependent upon the formation of a TJ permeability seal in the TE (reviewed
in Yamanaka et al., 2006; Bell et al., 2008). Changes in the permeability of this TJ seal
can be precisely assessed by applying a sensitive FITC-Dextran assay (Sheth et al., 2000;
Violette et al., 2006; Giannatselis et al., 2011). Following 12 h (Figure 3.6A) and 24 h
(Figure 3.6B) SB 220025 treatment, we observed a significant increase in FITC-dextran
accumulation into the blastocyst cavity compared to controls. This indicates that p38
MAPK activity regulates TE TJ permeability. We then analyzed the effects of blocking
p38 MAPK activity on blastocyst formation gene family expression by applying RTPCR to investigate the effects of SB 220025 treatment on zonula occludens (Tjp1),
Occludin (Ocln), and the Na/K ATPase beta 1-subunit (Atp1b1) mRNA levels (Kim et al.,
2004; Violette et al., 2006; Madan et al., 2007; Giannatselis et al., 2011). No significant
difference in Tjp1, Ocln, or Atp1b1 mRNA levels was observed among treatment groups
(data not shown).

Finally we assessed effects of treatment on TJP1 localization.

Blastocysts treated for 12 h (Figure 3.7 A-F) with SB 220025 displayed abnormal TJP1
cortical staining compared with control embryos. TJP1 is normally distributed along the
basolateral membrane in a smooth, continuous pattern (KSOMaa Figure 3.7A; merged
image 3.7D; SB 202474 Figure 3.7B; merged image 3.7E). TJP1 also co-localizes with
the cytoskeleton, which can be seen as yellow signal in the merged images of both
KSOMaa and SB 202474 treated embryos (KSOMaa Figure 3.7A; merged image 3.7D;
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SB 202474 Figure 3.7B; merged image 3.7E). In p38 MAPK inhibited embryos, TJP1
appears in tight foci at cell-cell contacts with punctate staining and there is a loss of
yellow signal to predominantly red signal indicating a loss of TJP1 co-localization with
actin (Figure 3.7C; merged image 3.7F).

The same punctate distribution along the

basolateral membrane and loss of yellow signal was observed in embryos treated after 24
h (Figure 3.8 A-F) of p38 MAPK inhibition. After 24 h, TJP1 localization was more
punctate (Figure 3.7C; merged image 3.7F; white arrows) along adjacent cell borders in
SB 220025 treated embryos compared to 12 h of treatment and compared to control
embryos (KSOMaa Figure 3.8A; merged image 3.8D; SB 202474 Figure 3.8B; merged
image 3.8E; yellow arrows). This punctate distribution was observed in 70% of embryos
treated for 12 h and 85% of embryos treated for 24 h with SB 220025 as scored by two
independent observers.
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Figure 3.4 TE Differentiation is not Affected by p38 MAPK Inhibition
CDX2 protein localization following treatment with KSOMaa, SB 202474, or SB
220025. Representative images of CDX2 after 24 h of treatment in KSOMaa (A), SB
202474 (B) or SB 220025 (C). CDX2 protein localization pattern did not vary after 24 h
(A-C). White arrows indicate ICM; Yellow arrows indicate TE. Blue = nucleus; Red =
F-actin; Green = CDX2; n=10-15 embryos in each group; scale bar = 10 microns.
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Figure 3.5 TE Polarization is not Affected by p38 MAPK Inhibition
CDH1 protein localization following treatment with KSOMaa, SB 202474, or SB
220025. Representative images of CDH1 after 24 h of treatment in KSOMaa (A), SB
202474 (B) or SB 220025 (C). CDH1 protein localization pattern did not vary after 24 h
(A-C; Merge images D-F).

Blue = nucleus; Red = F-actin; Green = CDH1; n=10-15

embryos in each group; scale bar = 10 microns.
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Figure 3.6 p38 MAPK Pathway Regulates TJ Permeability
To test TJ permeability, embryos were treated in KSOMaa. SB 202474, or SB 220025
then exposed to 40 kDa FITC-dextran. (A) After 12 h of treatment, a significant
difference was observed in the number of embryos displaying 40 kDa FITC-dextran
fluorescence within the blastocyst cavity between SB 220025 and control groups
(p≤0.05) n=3. (B) After 24 h of treatment, a significant difference was observed in the
number of embryos displaying 40 kDa FITC-dextran fluorescence within the blastocyst
cavity between SB 220025 and control groups (p≤0.05) n=3. Representative images of
embryos following 12 h or 24 h treatment of treatment with (C) 2 mM EGTA (positive
control), (D) KSOMaa, (E) SB 202474 or (F) SB 220025 using 40kDa FITC-dextran.
SEM; scale bars = 10 microns. n=3.
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Figure 3.7 Inhibition of p38 MAPK Affects TJP1 Distribution at 12h
TJP1 protein localization following treatment with KSOMaa, SB 202474, or SB 220025.
Representative images of TJP1 after 12 h (A–F) treatment. SB 220025 treatment affected
TJP1 localization after 12 h (A-C; Merged images (D-F), white arrows indicate punctate
staining of TJP1 along adjacent cell borders instead of the even distribution pattern
normally observed in control embryos (yellow arrows). Blue = nucleus; Red = F-actin;
Green = TJP1; n=10-15 embryos in each group; scale bar = 10 microns.
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Figure 3.8 Inhibition of p38 MAPK Affects TJP1 Distribution at 24h
TJP1 protein localization following treatment with KSOMaa, SB 202474, or SB 220025.
Representative images of TJP1 after 24 h (A–F) treatment. SB 220025 treatment affected
TJP1 localization after 24 h (A-C; Merged images (D-F), white arrows indicate punctate
staining of TJP1 along adjacent cell borders instead of the even distribution pattern
normally observed in control embryos (yellow arrows). Blue = nucleus; Red = F-actin;
Green = TJP1 n=10-15 embryos in each group; scale bar = 10 microns.
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3.3.5 Inhibition of p38 MAPK Signaling Reduces Aqp3 mRNA Expression and
Protein Detection
To complete our analysis of the effects of p38 MAPK inhibition on blastocyst formation
gene families, we investigated the effects of SB 220025 treatment on Aqp3 and Aqp9
mRNA levels. After 12 h of SB 220025 treatment, there was no significant difference in
Aqp3 or Aqp9 mRNA levels between treated and control groups (Figure 3.9A). After 24
h, Aqp9 mRNA levels were unaffected, however, Aqp3 mRNA levels were significantly
reduced in embryos treated with SB 220025 compared to controls (Figure 3.9B).
Protein staining as observed using confocal microscopy also revealed a similar pattern.
Embryos treated for 12 h had little or no difference in AQP3 detection (Figure 3.10 A-C).
However, embryos treated for 24 h displayed an obvious and consistent reduction in
AQP3 immunofluorescence intensity in p38 MAPK inhibited embryos (Figure 3.10 D-F).
AQP9 staining did not reveal any visible difference after either 12 h or 24 h time point
(data not shown).

3.3.6 Inhibition of p38 MAPK Signaling Increases Apoptosis in the Blastocyst
The results indicate that p38 MAPK regulates blastocyst expansion, zona hatching in
vitro, TJ permeability and Aqp3 mRNA levels. The timing of p38 MAPK inhibition is
critical as 12 h treated embryos recovered from treatment as demonstrated by their
resumption of cavitation following treatment and placement in drug free culture medium,
while 24 h treated embryos do not recover from treatment. For these reasons we
investigated whether p38 MAPK inhibition affected apoptosis in SB 220025 treated
embryos. Blastocysts treated for 12 h with SB 220025 displayed no significant difference
in apoptosis levels between groups (Figure 3.11A). However, embryos cultured for 24 h
in SB 220025 displayed a significant increase in apoptotic cells (11% ± 1%, Figure
3.11B) over that observed for controls (KSOMaa (6% ± 1%) and SB 202474 (6% ± 2%).
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Figure 3.9 Inhibition of p38 MAPK Affects Aqp3 mRNA Expression
Relative Aqp 3 and 9 mRNA levels following treatment. Quantitative RT–PCR was used
to determine the relative mRNA levels of Aqp 3 after 12 h (A) or 24 h (B) in SB 220025.
Aqp 3 and Aqp 9 mRNA were not significantly affected after (A) 12 h; n = 3, mean ±
SEM, P ≤ 0.05. Aqp 9 mRNA was not significantly affected after (B) 24 h; however, Aqp
3 mRNA was significantly decreased after 24 h. n = 3, mean ± SEM, P ≤ 0.05.
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Figure 3.10 AQP3 Immunofluorescence After 12 h and 24 h of p38 MAPK
Inhibition
AQP3 protein localization following treatment with KSOMaa, SB 202474, or SB 220025.
Representative images of AQP3 after 12 h (A–C) of p38 inhibition.

No apparent

difference in AQP3 immunofluorescence was observed between treated and control
embryos after 12 h. However, embryos treated with SB 220025 for 24 h (D-F) displayed
a clear and consistent reduction in AQP3 immunofluorescence compared to controls.
Green = AQP3; n=10-15 embryos in each group; scale bar = 10 microns.
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Figure 3.11 Inhibition of p38 MAPK Pathway Affects Apoptosis
Apoptosis following KSOMaa, SB 202474 or SB 220025 treatment for 12 h (A) and 24 h
(B). TUNEL was used to assess the level of apoptosis in blastocysts after having been
cultured in KSOMaa, SB 202474 or SB 220025 media for 12 h or 24 h. Embryos cultured
in KSOMaa, SB 202474 or SB 220025 for 12 h (A) displayed the same level of
apoptosis. Embryos cultured in SB 220025 for 24 h (B) displayed a significant increase in
apoptosis compared with controls; mean ± SEM, P ≤ 0.05. (C-G) Representative images
of embryos from TUNEL assay; (C) Negative control; (D) Positive control; (E)
KSOMaa; (F) SB 202474; (G) SB 220025; n = 4 replicates; 15-20 embryos in each
group.
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3.4 Discussion
Preimplantation development is the most vulnerable period of mammalian development
with the majority of human preimplantation embryos failing to reach the blastocyst stage
or implant (Ellish et al., 1996). With the increasing reliance on fertility clinics and
Assisted Reproductive Technologies (ARTs) to provide patients with an opportunity to
have children (Mesrogli et al., 1991; Sebastiani et al., 2009; Lee et al., 2010), research
focusing on understanding the mechanisms controlling preimplantation development and
also on how the environment affects that developmental program is increasingly needed.
Previous studies have demonstrated that Na/K-ATPase subunits, AJs, TJs and AQPs
contribute directly to the mechanism that enables the TE to oversee cavitation and
blastocyst formation (reviewed in Bell et al., 2009; Giannatselis et al., 2011). It is
necessary to define the intracellular signaling mechanisms that regulate the functions of
these gene products so that we can develop a comprehensive understanding of how
cavitation and blastocyst formation are coordinated. We have recently demonstrated that
the Na/K-ATPase, in addition to its well known ion transport function can also serve as a
mediator of ouabain induced Src activation that regulates TJ function and blastocyst
formation (Giannatselis et al., 2011). The present study, with its focus on p38 MAPK,
probed the role of pathways that may be downstream of Src and investigated their
contributions to cavitation and blastocyst formation.
In the present study we have demonstrated that p38 MAPK regulates cavitation and
overall blastocyst formation. More importantly we have uncovered several components of
the p38 MAPK mediated role by demonstrating that p38 MAPK inhibition in early
blastocysts is accompanied by an increase in TE tight junction permeability, shifts in
TJP1 localization, down regulation of Aqp3 mRNA levels, reduced AQP3 detection and
increased apoptosis. Together these outcomes place p38 MAPK as a likely intracellular
signaling mediator that coordinates the function of the blastocyst formation family genes
in regulating cavitation and blastocyst formation. The consistency of outcomes observed
regarding the effects to blastocyst cavity expansion for both CSAID treatments employed
in this study, and the absence of observable effects to the ERK MAPK pathway during
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these treatments, support our conclusion that the effects we have observed are attributable
to a blockade of p38 MAPK activity.
We were concerned that the outcomes on blastocyst expansion following CSAID
treatment may be related to effects on TE differentiation or TE polarity. CDX2 activity is
regulated by p38 MAPK phosphorylation in intestinal epithelial cell differentiation
(Houde et al., 2001) and additionally, p38 MAPK regulates Cdh1 expression during
gastrulation, a process that occurs immediately following implantation (Rossant et al.,
1997; Rossant, 2004; Behr et al., 2005). We therefore sought to determine if p38 MAPK
regulated CDX2 and CDH1 localization or detection in the blastocyst. Our outcomes
demonstrated no effect of CSAID treatment on CDX2 or CDH1 localization suggesting
that TE differentiation and polarity were already well established and likely unaffected by
the CSAID treatment used in this study. We applied our studies exclusively to cavitating
blastocysts (89 hr post-hCG) so that we could focus specifically on investigating the role
of p38 MAPK on blastocyst cavitation. It may be possible that p38 MAPK does affect TE
differentiation and TE polarity but to determine this, experiments would have to be
directed to earlier stages of development prior to the onset of cavitation. Thus, the
maintenance of TE differentiation and polarity as indicated by normal CDX2 and CDH1
localization patterns ensure that the outcomes observed in our study pertain specifically
to p38 MAPK regulation of cavitation and are not due to secondary or indirect influences
due to disruption of TE differentiation or polarity.
From these experiments, we were also able to conclude that F-actin was present and
properly localized in p38 MAPK inhibited embryos. Our studies did not observe any
changes in staining intensity of F-actin in p38 MAPK inhibited blastocyst unlike those
reported by Natale et al. 2004 and Paliga et al., 2005. Natale et al., 2004, and Paliga et
al., 2005, demonstrated that p38 MAPK signaling was required at the 8-16 cell stage for
normal blastocyst development through its regulation of heat-shock protein 25/27 which
stabilizes F-actin. F-actin stability was restored after p38 MAPK inhibition was removed
and embryos were placed in new culture drops and allowed to progress to the blastocyst
stage (Natale et al., 2004; Paliga et al., 2005). The differences we have observed between
our two studies could be indicative of a stage specific role that p38 MAPK plays at the 8-
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16 cell stage versus the blastocyst stage. This result supports the hypothesis that p38
MAPK signaling regulates different cellular responses at the 8-16 cell stage from the
blastocyst stage of preimplantation development and this may represent an important
process of signaling maturation that the preimplantation embryo acquires as it advances
towards the blastocyst stage and prepares for implantation. Gene deletion studies have
demonstrated that p38 MAPK

is required for successful development with knockout

mice suffering a developmental lethality by day 10.5 of pregnancy (reviewed in Aouadi
et al., 2006). Each CSAID compound targets both p38 MAPK

and

forms and thus

while preimplantation embryos may be able to complete this developmental interval in
the absence of p38 MAPK

we would suggest that our collective results demonstrate

that targeting both p38 MAPK

and

using CSAID treatment results in a cessation of

preimplantation development and erosion of the adaptive mechanisms that early embryos
use to adjust to the environment (Jackson et al., 1998, Natale et al., 2004; Paliga et al.,
2005; Fong et al., 2008; Bell et al., 2009). These results indicate that p38 MAPK is an
important mediator of preimplantation embryo development and environmental adaptive
responses (Natale et al., 2004; Paliga et al., 2005; Fong et al., 2008; Bell et al., 2009).
We observed a considerable effect of CSAID treatment time on blastocyst cavitation and
zona hatching in this study. Clearly both a 12 h and 24 h treatment time had a significant
negative effect on blastocyst cavitation and zona hatching in vitro. The effects of 12 h
treatment were less severe than the 24 h treatment. Embryos treated for 12 h displayed an
ability to resume expansion after treatment while those treated for 24 h did not. In
addition, both treatment times resulted in a blockade of zona hatching in vitro even after
placement in fresh culture drops and allowed to recover. Our interpretation of these
outcomes is that the 12 h treatment simply slowed down the developmental program
sufficiently to prevent the treated embryos from fully catching up to their untreated
controls during the recovery period. The majority of the controls had advanced to become
fully expanded, zona hatched blastocysts by the end of the experimental and the treatment
recovery periods. This outcome mirrors our observations of the effects of CSAID
treatment on cleavage stage embryos, where we observed that they proceeded to the
blastocyst stage in normal frequencies once CSAID treatment was halted but this advance
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was accompanied with a substantial time delay (Natale et al., 2004; Paliga et al., 2005).
The 12 h treated blastocysts in the present study were clearly advancing following
CSAID treatment, but the recovery period was not long enough to allow them to become
synchronized once again with their control counterparts (Natale et al., 2004; Paliga et al.,
2005). The 24 h treated blastocysts displayed a very different outcome as they were
unable to resume expansion following CSAID treatment.

Our interpretation of this

outcome is based upon our knowledge of the duel function that p38 MAPK plays during
preimplantation development. We would suggest that the 24 h treatment was sufficiently
long enough to deprive the embryo of a key component of its adaptive mechanism to
environmental stress resulting in an inability of the embryo to recover following
treatment (Reviewed in Cargnello et al., 2011; Fong et al., 2007; Aouadi et al., 2006;
Natale et al., 2004; Bell et al., 2009). This interpretation is supported by our results, for
apoptosis was unaffected by the 12 h CSAID treatment period, but the 24 h treatment
period was accompanied by a significant increase in apoptosis. Studies have clearly
demonstrated that it is the JNK/SAPK pathway that regulates apoptosis in the
preimplantation embryo, especially following environmental stress (Xie et al., 2003;
Wang et al., 2005; Xie et al., 2006; Bell et al., 2009). We would propose that the
extended 24 h CSAID treatment time and its accompanying failure to resume cavitation
and increased apoptosis are reflective of the effects of environmental stress on the
embryo due to the prolonged inhibition of a key component of the embryo’s stress
response adaptive mechanisms (Fong et al., 2008; Bell et al., 2009). The down regulation
of Aqp3 mRNA levels and reduced AQP3 detection observed only at the 24 h treatment
time is certainly consistent with this interpretation of our results. A decline in Aqp3
mRNA levels and reduced AQP3 detection are suggestive that facilitated fluid movement
across the TE may be impeded by 24 h CSAID treatment. If so, this would certainly
contribute to the inability of 24 h CSAID treated embryos to resume expansion following
treatment and this outcome is consistent with our earlier report that demonstrated that p38
MAPK regulates Aqp mRNAs levels in cleavage stage embryos (Bell et al., 2009).
Finally, the increased FITC-dextran permeability we observed following 12 h and 24 h
CSAID treatment is consistent with our earlier studies (Violette et al., 2006; Giannatselis
et al., 2011). Strippoli et al., 2010 investigated the role of p38 MAPK during epithelial-
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to-mesenchymal transition (EMT) and demonstrated that loss of p38 MAPK signaling
during EMT resulted in disorganized and loss of expression of TJP1 in human
mesothelial cells (Strippoli et al., 2010). Collectively, these studies provide an
understanding of the mechanisms that control TJ function during cavitation and reinforce
our understanding of the role the TJ permeability seal plays in regulating cavitation and
blastocyst formation (Violette et al., 2006; Madan et al., 2007; Giannatselis et al., 2011).
Our recent studies have demonstrated that the Na/K-ATPase is an upstream regulator of
TE TJ permeability and this mechanism is modulated by Src phosphorylation (Violette et
al., 2006; Madan et al., 2007; Giannatselis et al., 2011). The present study has implicated
p38 MAPK as a likely downstream intermediary from Na/K-ATPase and Src regulation
of TE TJ function. In conclusion, our results support an important role for p38 MAPK in
mediating cavitation and blastocyst expansion and suggest that it is an important mediator
of blastocyst formation gene family expression, function and thus coordination of the
overall events that regulate blastocyst formation.
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CHAPTER FOUR
SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell
Stage and Become Segregated to the TE in the Mouse
Blastocyst

A version of this chapter has already been published:

Bell, C. E., & Watson, A. J. (2009). SNAI1 and SNAI2 are asymmetrically expressed at
the 2-cell stage and become segregated to the TE in the mouse blastocyst. PLoS ONE,
4(12)

145

4.1 Introduction
Preimplantation development is characterized by the differentiation of two distinct cell
types, inner cell mass (ICM) which will form the embryo proper and the trophectoderm
(TE) which will contribute to the embryonic portion of the placenta (Yamanaka et al.,
2006). The TE is a polarized, epithelial cell type and the development of the TE is the
first differentiation event to occur throughout mammalian development. The cell polarity
model proposes that TE differentiation is initiated at the 8-cell stage and that TE cell fate
occurs through the establishment of cell polarity along the length of each blastomere
forming an apical and basolateral membrane (Yamanaka et al., 2006). If a blastomere
undergoes symmetric division, each daughter cell inherits equally the apical and
basolateral membrane, will remain polarized, and contribute to the TE (Yamanaka et al.,
2006). If a blastomere undergoes asymmetric division, each daughter cell inherits a
distinct portion of the polarized membrane, either apical and basolateral or just
basolateral, resulting in the differentiation of a TE cell and an ICM cell respectively
(Yamanaka et al., 2006). Prior to the compacted 8-cell stage in the mouse however,
blastomeres are totipotent and can contribute to all cell types of the blastocyst (Rossant et
al., 1976). The outer embryonic blastomeres that do go on to form the TE acquire several
critical gene products such as Na/K-ATPase (Watson & Kidder 1988; Violette et al.,
2006; Madan et al., 2007), tight junctions (Flemming et al., 1989) and adherens junction,
aquaporins (Johnson & McConnell JM 2004), and several transcription factors, such as
caudal homeobox 2 (CDX2) (Strumpf et al., 2005) which define the TE cell lineage and
orchestrate its function during blastocyst formation.
Recently, Na/K-ATPase β1 subunit expression has been shown to be regulated in cell
lines by the two TFs, SNAI1 (previously known as SNAIL) and SNAI2 (previously
known as SLUG) (Espineda et al., 2004). SNAI1 expression was increased in MDCK
cells resulting in the down-regulation of the Na/K-ATPase β1. E-cadherin expression was
also down-regulated resulting in the loss of cell-cell contacts (Espineda et al., 2004).
Conversely, SNAI2 expression promoted Na/K-ATPase β1 subunit expression by
inhibiting SNAI1 expression (Espineda et al., 2004). Aberrant expression of SNAI1
(Carver et al., 2001; Hotz et al., 2007; Peinado et al., 2007) and SNAI2 (Rukstalis &
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Habener, 2007; Yoshino et al., 2007) is also linked to cancer metastasis in epithelial cell
lines through its role in directing epithelial-to-mesenchymal cell transition (EMT).
SNAI1 and SNAI2 direct the loss of polarity in epithelial cells by down-regulating Ecadherin expression resulting in EMT. Once EMT has occurred, a cell is no longer
adherent to its neighbors and re-engages cell proliferation and metastasis programs
(Rukstalis & Habener, 2007). Snai1 knock-out studies in mice have revealed a role for
SNAI1 in neural crest differentiation (Carver et al., 2001). Snai2 knock-out mice do not
display an embryonic lethality and survive to birth (Jiang et al., 1998). Since SNAI1 and
SNAI2 are important mediators of E-cadherin and Na/K ATPase β1 subunit expression,
(necessary components for TE differentiation and maintenance), we have characterized
Snai1 and Snai2 expression throughout mouse preimplantation development and TE
differentiation. Our results have revealed a novel and unexpected protein localization
pattern for SNAI1 and SNAI2 in the 2-cell and 4-cell embryo and have demonstrated that
SNAI1 and SNAI2 become confined solely to the outer cells, TE cell lineage of the early
embryo and are not present in the inner cell, ICM lineage of the embryo.

4.2 Materials and Methods
4.2.1 Collection of Preimplantation Embryos
Mouse embryos were obtained from random-bred MF1 females super ovulated with
Pregnant Mare's Serum Gonadotropin (PMSG) and human Chorionic Gonadotropin
(hCG), and mated with CD1 males. Successful mating was determined the next morning
(day 1) by the presence of a vaginal plug. Embryos were collected at specified times
following hCG injection, which correspond to appropriate cleavage stages: 1-cell
inseminated zygotes, 18-hr post-hCG; 2-cell, 48 hr; 4-cell, 60 hr; 8-cell, 65–68 hr;
compacted embryo, 80–85 hr and blastocysts, 90 hr. Embryos were then washed in 50 µl
M2 media and frozen in groups of 20 for quantitative RT-PCR analysis or fixed for whole
mount immunofluorescence detection of SNAI1 and SNAI2 proteins.
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4.2.2 Mouse Fibroblast NIH 3T3 Cell Culture
NIH 3T3 cells were plated in 6-well culture dishes at a density of 5×103 cells/cm2. Cells
were cultured in complete medium supplemented with 10% fetal bovine serum (Sigma, St
Louis, MO), 1% Antibiotics (Sigma) in DMEM. Cells were trypsinized with 1X trypsin
for 1 min at 37°C, harvested in 3–5 ml complete medium and centrifuged for 5 min at
4000×g. Cells were re-suspended in 10 ml complete medium and plated on chamber
slides for immunofluorescence analysis or on 15 cm plates for protein analysis. Cells
were cultured for 2 days until they reached confluence and fixed for immunofluorescence
or lysed for whole cell lysate collection.
4.2.3 Quantitative RT-PCR
Quantitative RT-PCR was conducted to determine the mRNA profile of Snai1 and Snai2
at the 1-cell, 2-cell, 4-cell, 8-cell, compacted embryo and blastocyst stages. Prior to RNA
extractions, Luciferase mRNA, an exogenous control, was added to the samples. Total
RNA was extracted from pools of 20 embryos using the PicoPure kit (Arcturus,
Molecular Device, Sunnyvale, CA). Reverse Transcription reaction was carried out using
Sensiscript reverse transcriptase (Qiagen, Mississauga, ON). The samples were incubated
in 10x buffer, RNAse inhibitor, dNTPs and random primers at 37°C for 1 hr. Quantitative
PCR reactions were performed using the BioRad Chromo4 detection system (BioRad,
Mississauga, ON). PCR was carried out in 25 µl reactions containing 12.5 µl Multiplex
Universal PCR Master Mix (2X concentration solution optimized for multiplex reactions,
BioRad), 1.25 µl of SNAI1 and SNAI2 primer/probe sets provided by Biosearch
Technologies (Novado, CA), or SYBR Green (Invitrogen, Burlington, ON) and 5 µl of
appropriate dilution of cDNA (0.1 embryo/µl), and 6.25 µl of water. Snai1 primer
sequence 5′-CATCCTCGCTGGCATCTTCC-3′; 3′-GAGAGCCAAGCAGGAACCAG5′;

Snai2

primer

sequence

5′-CTTTACCCAGTGGCCTTTCTC-3′;

3′-

CCACAGATCTTGCAGACACAA-5′.
4.2.4 Whole-Mount Immunofluorescence
Protein localization was investigated using whole-mount immunofluorescence methods
for both SNAI1 and SNAI2 throughout preimplantation development. Embryos were
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fixed in 2% paraformaldehyde in PBS and then incubated in primary rabbit polyclonal
anti-SNAI1 (ab 17732, Abcam, Cambridge, MA and gift from Dr. Paul Wade and Dr.
Archana Dhasarathy) or rabbit polyclonal anti-SNAI2 antibodies (ab27568, Abcam).
Negative controls were incubated in antibody dilution buffer alone. NIH 3T3 cells were
fixed in 4% paraformaldehyde in PBS for 20 min. Cells were then washed and incubated
with primary SNAI1 or SNAI2 antibody. Negative control cells were incubated in
antibody dilution buffer alone. Antibody specificity was determined by conducting
immuno-pre-absorption assays with either a SNAI1 peptide (Abcam) for the SNAI1
antiserum or a SNAI2 peptide (Abcam) for the SNAI2 antiserum. Fixed embryos were
then incubated in either SNAI1 or SNAI2 antisera alone, or in the pre-absorption
antibody solution. Embryos and cells were examined by confocal microscopy using an
Olympus Fluoview 1000 laser scanning Confocal Microscope (Olympus, Canada). Zstack images were taken of the embryos and used to count total cell number and SNAI1
or SNAI2 positive cells.
4.2.5 Western Blot
NIH 3T3 cells were lysed, on ice, using RIPA buffer with Protease inhibitors. Cells were
then scraped into the RIPA buffer and homogenized by repeated pipetting. Cell lysate
was removed and placed into a 1.5 ml tube and centrifuged at 4000×g for 5 min. The
supernatant was removed and stored at −80°C. Protein Quantification was performed
using DC Protein Assay kid (BioRad) and a spectrophotometer. A 12% acrylamide
stacking gel was used and 40 mg of protein was loaded into each lane. Antiserum
dilutions employed included SNAI1 anti-serum (1:1000); SNAI2 antiserum (1:2000); and
secondary antibody (Anti-Rabbit IgG HRP-linked (Cell Signalling, Danvers, MA) at
1:10000). Antiserum pre-absorption assay was performed prior to membrane incubation.
4.2.6 Microinjection of siRNAs
Microinjection was performed under an inverted microscope using a mechanical
micromanipulator (Leica, Richmond Hill, ON, CA) attached to Picoinjector PLI-100
(Harvard Apparatus, Saint-Laurent, PQ, CA). 1-cell embryos were injected with either
negative control (Invitrogen) or siRNA duplexes targeting Snai1 or Snai2. Microinjection
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of embryos was performed according to a standard procedure. One-cell embryos were
placed on a concave watch glass and into KSOMaa medium under light mineral oil. A
holding pipette (Conception Technologies, San Diego, CA) was used to keep the one-cell
embryos stationary during manipulation. An injection pipette loaded with siRNA solution
was inserted into the cytoplasm of each zygote followed by the microinjection of
approximately 20 pl of 20 µM of dsRNA. After microinjection, embryos were cultured in
KSOMaa medium as described above for 48 hours and fixed at the 4–8 cell stage and
used for whole-mount immunofluorescence as described above.
4.2.7 Statistics
Quantitative RT-PCR and whole-mount immunofluorescence were performed in
triplicate using pools of embryos at each stage collected from 3 groups of mice. Data was
analyzed using the SigmaStat® 3.5 (Jandel Scientific Software, San Rafael, CA, USA).
Upon acceptance of normality tests, the data was analyzed using a One-way ANOVA
followed by a Bonferroni multiple comparison test. If the data failed the normality test, it
was analyzed using an ANOVA on ranks, followed by a Dunn's multiple comparison test.

4.3 Results
4.3.1 Quantitative RT-PCR of Snai1 and Snai2 Throughout Preimplantation
Development
When quantitative RT-PCR was performed on each developmental stage (1-cell, 2-cell,
4-cell, 8-cell, compacted embryo, blastocyst), it revealed that Snai1 and Snai2 transcripts
were differentially regulated throughout preimplantation development (Figures 4.1A and
4.1B respectively). Snai1 transcripts were detected as early as the 1-cell stage, and then
Snai1 was significantly up-regulated at the 2-cell stage followed by down regulation at
the 8-cell stage and return to baseline levels at the blastocyst stage (Figure 4.1A).
Detection of Snai1 throughout preimplantation development confirms previously reported
detection by Veltmaat et al., 2000; however, here we report relative levels of Snai1.
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Figure 4.1 Characterization of Snai1 and Snai2 Expression
(A) Snai1 transcripts were detected using quantitative RT-PCR using pools of 20 freshly
flushed embryos, at each stage of development (1-cell, 2-cell, 4-cell, 8-cell, compacted
embryo and blastocyst); n = 3, p ≤ 0.05 ±S.E.M. (B) Snai2 transcripts were detected
using quantitative RT-PCR using pools of 20 freshly flushed embryos, at each stage of
development (1-cell, 2-cell, 4-cell, 8-cell, compacted embryo and blastocyst); n = 3, p ≤
0.05 ± S.E.M.
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4.3.2 Whole Mount Immunofluorescence of SNAI1 and SNAI2 Throughout
Preimplantation Development
As revealed by Snai1 knock-out studies, SNAI1 plays a role in neural crest differentiation
during mouse development (Carver et al., 2001). Snai2 knock-out mice, alternatively, are
able to survive to birth (Jiang et al., 1998). Although there is no preimplantation lethality
in the Snai1 or Snai2 knock-out, the potential does exist that oogenetic proteins are
sufficient to maintain viability past the preimplantation stage in the Snai1 and Snai2
nulls. Whole-mount immunofluorescence and confocal microscopy were used to
investigate freshly flushed embryos at each preimplantation developmental stage and
revealed a unique distribution pattern. SNAI1 localization appears in discrete fluorescent
foci in cortical regions throughout the zygote (Figure 4.2A). SNAI2 localization is
symmetrical however; there are areas with increased intensity throughout the zygote
(Figure 4.2B). SNAI1 and SNAI2 protein immunofluorescence revealed a variety of
distribution patterns at the 2-cell stage including an asymmetrical localization within
individual blastomeres. In 6% of 2-cell embryos, SNAI1 was not detectable, while in
94% of 2-cell embryos SNAI1 was detectable but displayed variable localization patterns
that consisted of either symmetrical or asymmetrical localization patterns within one or
both blastomeres of a 2-cell embryo (Figure 4.3A). 16% of 2-cell embryos displayed a
pattern where SNAI1 was asymmetrical in one blastomere and not expressed in the
second blastomere, 9% displayed symmetrical distribution in one blastomere and no
detection in the second, 16% displayed an asymmetrical and symmetrical pattern, 25%
both asymmetrical and 28% where both blastomeres displayed symmetrical distribution
(Figure 4.3A). Furthermore, SNAI1 was consistently detectible in the cytoplasm,
however although SNAI1 is a transcription factor, nuclear localization was not commonly
observed.
In contrast, SNAI2 was localized to both the cytoplasm and nucleus in positive
blastomeres throughout preimplantation development. SNAI2 also displayed both
asymmetrical and symmetrical distribution patterns at the 2-cell stage (Figure 4.3B). 16%
of 2-cell embryos displayed symmetrical cytoplasmic localization in both blastomeres, in
40% both blastomeres were asymmetrical and 36% where both blastomeres displayed
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symmetrical distribution and weak localization to the nuclei. 8% of 2-cell embryos
displayed a pattern where in one blastomere SNAI2 was asymmetrical, localized to one
pole of the blastomere but not expressed in the nucleus or in the second blastomere
(Figure 4.3B)
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Figure 4.2 Localization of SNAI1 and SNAI2 in the 1-cell Zygote.
(A) SNAI1 localization appears in discrete fluorescent foci in cortical regions throughout
the zygote; n = 9. (B) SNAI2 localization is symmetrical however, there are areas with
increased intensity throughout the zygote; n = 10. Red = Filamentous Actin; Blue =
Nuclei; Green = SNAI1 or SNAI2. Scale bars = 10 microns.
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Detection of SNAI1 and SNAI2 at the 4-cell stage also revealed a variety of distribution
patterns, including asymmetrical localization within individual blastomeres (Figures 4.4A
and 4.4B). Localization patterns included 4-cell embryos expressing SNAI1 in all
blastomeres, 3 of the 4 blastomeres, or only 2 blastomeres (Figure 4.4A).
SNAI1 and SNAI2 were detected in the majority of blastomeres at the 8-cell stage
(Figures 4.5A and 4.5B respectively). SNAI1 was either asymmetrically expressed or
symmetrically expressed within an individual 8-cell blastomere, however this pattern was
consistent across all 8-cell embryos. Asymmetrical expression of SNAI2 was also
observed within an individual 8-cell stage blastomere, however symmetrically distributed
SNAI2 was the most common pattern observed (Figure 4.5B). In the compacted embryo,
SNAI1 and SNAI2 proteins become confined to the outer cells only and the inner cells no
longer displayed SNAI1 or SNAI2 immunofluorescence (Figures 4.5A and 4.5B). This
localization pattern of SNAI1 and SNAI2 persists throughout development resulting in
the detection of SNAI1 and SNAI2 only in the TE of the blastocyst (Figures 4.5A and
4.5B). Cell counts performed at the 8-cell, compacted embryo and blastocyst stage
revealed the percentage of SNAI1 and SNAI2 positive cells significantly decreased as
embryos progressed to the blastocyst stage. As the blastocyst matures and becomes fully
expanded, SNAI1 and SNAI2 were decreasingly detected in all TE cells (filled yellow
arrow indicates positive staining for SNAI1 (Figure 4.5A) and SNAI2 (Figure 4.5B);
filled red arrow indicates negative SNAI1 TE cell (Figure 4.5A) and negative SNAI2 TE
cell (Figure 4.5B).
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Figure 4.3. Representative Images of SNAI1 and SNAI2 Localization at the 2-cell
stage.
(A) Embryos were categorized based on SNAI1 localization; n = 32, three replicates.
(B) Embryos were categorized based on SNAI2 localization; n = 25, three replicates.
Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 (A) or SNAI2 (B). Scale bars =
10 microns.
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Figure 4.4 Representative Images of SNAI1 and SNAI2 Localization at the 4-cell
Stage.
(A) Embryos were categorized based on SNAI1 localization; n = 15, three replicates.
(B) Embryos were categorized based on SNAI2 localization; n = 18, three replicates.
Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 (A) or SNAI2 (B). Scale bars =
10 microns.
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Figure 4.5 Representative Images of SNAI1 and SNAI2 Localization at the 8-cell,
Compacted Embryo and Blastocyst Stage
(A) SNAI1 protein expression pattern at the 8-cell, compacted embryo, and blastocyst
stages. The number of blastomeres expressing SNAI1 versus the total number of
blastomeres at each stage was counted. 8-cell (n = 16); Compacted embryo (n = 10);
Blastocyst (n = 13); * = p≤ 0.05; *** = p≤ 0.001, ±S.E.M. Red = Filamentous Actin;
Blue = Nuclei; Green = SNAI1. Scale bars = 10 microns.
(B) SNAI2 protein expression pattern at the 8-cell, compacted embryo, and blastocyst
stages. The number of blastomeres expressing SNAI2 versus the total number of
blastomeres at each stage was counted. 8-cell (n = 20); Compacted embryo (n = 12);
Blastocyst (n = 10); * = p≤ 0.05, ±S.E.M. Red = Filamentous Actin; Blue = Nuclei;
Green = SNAI2. Scale bars = 10 microns.
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4.3.3 Validation of SNAI1 and SNAI2 Antisera
Due to the unique nature of the protein localization patterns we report in our study, we
were especially vigilant regarding the specificity of the antisera employed in this study.
Antibody peptide pre-absorption controls were conducted using preimplantation embryos.
Detection of SNAI1 and SNAI2 was lost in embryos incubated with peptide pre-absorbed
antisera compared to embryos incubated in non-pre-absorbed antisera alone (Appendix B:
Supplemental Figures 1A and 1B, respectively). In addition, we knocked down SNAI1
and SNAI2 by microinjecting siRNA into 1-cell embryos targeting either Snai1 or Snai2.
SNAI1 and SNAI2 were distinctly knocked down but were still weakly detectable in the
siRNA injected embryos. This reduction of SNAl1 and SNAI2 fluorescence further
verifies the specificity of the antisera employed in this study (Appendix B: Supplemental
Figures 1C and 1D). We next confirmed the localization patterns of these antisera in
published cell models using the same antisera. SNAI1 and SNAI2 immunofluorescence
applied to NIH 3T3 cells demonstrated a normal (i.e. nuclear and cytoplasmic
distribution) SNAI1 and SNAI2 localization compared to previously published data
(Appendix B: Supplemental Figures 2A and 2B respectively; (Appendix B: Supplemental
Figure 1C is the negative control)) (Franci et al., 2006). We also applied Western Blot
analysis, which revealed single and appropriate sized bands for SNAI1 and SNAI2
(Appendix B: Supplemental Figure 2D). Furthermore, a peptide pre-absorption assay was
also performed for the Western blot analysis revealing that the SNAI1 and SNAI2 bands
were no longer detectible using pre-absorbed antisera (Appendix B: Supplemental Figure
2D). These experiments conclusively show that the SNAI1 and SNAI2 antisera employed
in this study are specific for SNAI1 and SNAI2, respectively.

4.4 Discussion
This study sought to characterize the expression of the Snai1 and Snai2 throughout
preimplantation development. Our results have revealed a novel, asymmetrical protein
distribution of SNAI1 and SNAI2 within the early preimplantation embryo. Snai1 and
Snai2 transcripts are detectible throughout preimplantation development. SNAI1 and
SNAI2 have variable expression at the 2-cell and 4-cell stage including asymmetrical and
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symmetrical localization within individual blastomeres. SNAI1 and SNAI2 are detected
in the majority of blastomeres at the 8-cell stage, however, protein localization varies
between blastomeres within a single embryo. SNAI1 and SNAI2 are then localized to the
outer cells in the compacted embryo and are localized only in TE cells of the blastocyst.
The Snai1 pattern of mRNA accumulation does not follow the general pattern of mRNA
transcript expression throughout mouse preimplantation development where oogenetic
transcripts are largely degraded by the 2-cell stage and then replaced by embryonic
expression that drives transcript accumulation after the maternal-to-zygotic transition
occurs (Bell et al., 2008). This expression pattern supports a novel role for SNAI1 during
the maternal-to-zygotic transition (MET), as its expression is linked closely with the
onset of the MET. This is further supported by studies conducted in zebrafish that
demonstrate an increase in Snai1 transcript during the onset of MET (Hammerschmidt &
Nüsslein-Volhard, 1993). Snai2 transcripts do decrease at the 2-cell stage and therefore
more closely follow the typical MET pattern of mRNA transcript abundance during
mouse preimplantation development.
Asymmetrical protein localization in early embryonic blastomeres has been reported by
Antczak and Blerkhome, 1997. They reported that Leptin and STAT3 were both
asymmetrically expressed in the oocyte and after fertilization, were subsequently
distributed unevenly to daughter blastomeres at the 4-cell and 8-cell stage. Consequently,
Leptin and STAT3 became distributed in outer cells of the compacted embryo and then in
select cells of the TE, leading to the hypothesis that Leptin and STAT3 distribution may
contribute to lineage segregation. SNAI1 and SNAI2 are also asymmetrically localized;
however, unlike Leptin and STAT3, SNAI1 and SNAI2 are expressed in all cells of the 8cell stage and are not asymmetrically expressed in the outer cells of the compacted
embryo or TE of the blastocyst. One similarity is that SNAI1 and SNAI2, like STAT3
and Leptin are expressed in certain cells of the TE in the expanded blastocyst, but not all.
It would be interesting to determine if STAT3 and Leptin expression coincided with
SNAI1 and SNAI2 expression in the blastocyst (Antczak & Van Blerkom, 1997). In other
vertebrates and invertebrates asymmetrical protein expression is more common (ex.
Xenopus) (Chan & Etkin, 2001). Asymmetrical expression of proteins in other species

164
plays a role in differentiation by the allocation of that protein to distinct cell lineages
through subsequent cellular divisions (Chan & Etkin, 2001). Lineage tracing studies
would have to be performed to determine segregation of SNAI1 and SNAI2 between the
2-cell to 4-cell division in the mouse embryo. Furthermore, it has been demonstrated that
each blastomere at the 8-cell stage retains the ability to contribute to all cell lineages of
the early embryo and thus is referred to as being “totipotent” (Yamanaka et al., 2006).
Our results indicate that blastomeres at the 2-cell, 4-cell and 8-cell stages do not all
localize SNAI1 or SNAI2 equally and thus while all early blastomeres may display
totipotence, they are not all equivalent. This variable pattern of SNAI1 and SNAI2
localization may be regulated by the cell cycle as early blastomeres undergo
asynchronous cell divisions. However, the asymmetrical SNAI1 and SNAI2 localization
patterns within individual blastomeres cannot result from cell cycle variation between
blastomeres and likely results from cytoskeletal based mechanisms within the cell.
Our data do not allow us to conclude that SNAI1 or SNAI2 are active contributors to cell
fate decisions during preimplantation development, but certainly SNAI1 and SNAI2 are
markers of cell fate decisions as their distribution patterns reflect the cell lineage
decisions that occur during the first week of development. It is intriguing to propose that
blastomeres displaying variable SNAI1 and SNAI2 localization patterns may divide in
varying planes, which would produce an uneven inheritance of SNAI1 or SNAI2 to the
daughter blastomeres, and thus contribute to cell fate decisions in the early embryo.
Alternatively, blastomeres that have symmetrical distribution of SNAI1 or SNAI2 may
divide radially, where both daughter blastomeres would inherit SNAI1 or SNAI2. Our
studies will pursue the determination of the role(s) that SNAI1 and SNAI2 play in
preimplantation development and possible cell fate decisions.
It has been proposed that blastomeres at the 2-cell stage are fated to contribute to the
embryonic or abembryonic portion of the embryo (Bischoff et al., 2008). Furthermore,
studies have suggested that 4-cell blastomeres are not equally pluripotent due to the
manner in which 2-cell blastomeres cleave resulting in an uneven distribution of products
across the blastomeres (Torres-Padilla et al., 2007). Our results demonstrate that SNAI1
and SNAI2 are unevenly distributed at the 2-cell stage and the 4-cell stage, however,
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careful analysis has demonstrated that SNAI1 and SNAI2 can be found in all blastomeres
at the 4-cell stage regardless of blastomere position. Furthermore, SNAI1 and SNAI2 are
expressed in all blastomeres at the uncompacted 8-cell stage and are expressed in all
outer cells of the compacted embryo and in both the abembryonic and embryonic portions
of the TE in the expanded blastocyst.
This study reveals asymmetrical distribution of SNAI1 and SNAI2 as early as the 2-cell
and 4-cell stage of preimplantation development, far earlier than previously thought. Not
only are SNAI1 and SNAI2 asymmetrically distributed within early cleavage stage
blastomeres but their expression is lost in the ICM coincident with cell lineage
specification and the formation of outer and inner cell lineages in the early embryo. This
may indicate that SNAI1 and SNAI2 may contribute to cell polarization and epithelial
cell differentiation. Collectively, this study provides novel insight into the potential role
of SNAI1 and SNAI2 in development and cancer metastasis.
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CHAPTER FIVE

GENERAL DISCUSSION
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5.1 General Discussion
The morphological events characterizing preimplantation development are well
documented, however the molecular events governing preimplantation development must
be further elucidated. In this thesis, I have endeavored to further elucidate the adaptive
and developmental role that MAPK pathways play throughout preimplantation
development. The specific objectives were:
Chapter 2: Determine (1) the effects of culture medium hyperosmolarity on Aqp gene
expression and apoptosis and (2) the role of the MAPK and JNK/SAPK pathways on Aqp
gene expression and apoptosis using pharmacological inhibitors.
Chapter 3: Determine the effects of p38 MAPK inhibition on blastocyst cavitation and
expansion, hatching frequency and apoptosis levels, TJ permeability, TJP1 localization
and distribution, TE differentiation and polarization, and Aqp3 expression and AQP3
localization.
Chapter 4: Characterize SNAI1 and SNAI2 expression and localization throughout
preimplantation development.
The objective of study one was to determine how MAPK pathways governed the
preimplantation embryo’s response to osmotic stress. Preimplantation embryos were
cultured in hyperosmotic media from the 8-cell stage for 3h, 6h and 24h and expression
and localization of Aqp3 and Aqp9 were assessed. I demonstrated that in response to
hyperosmotic stress, Aqp3 and Aqp9 expression was elevated and AQP3 and AQP9
localization was affected. To determine if p38 or JNK/SAPK, two MAPK pathways that
are activated in response to hyperosmotic stress, were affecting Aqp3 or Aqp9 expression,
we cultured embryos in hyperosmotic media in the presence of a p38 MAPK inhibitor
(SB 220025), or a JNK/SAPK MAPK inhibitor (SP 600125). In the presence of the p38
MAPK inhibitor, Aqp3 and Aqp9 expression was no longer elevated in response to
hyperosmotic media.

The JNK/SAPK inhibitor had no effect on Aqp3 and Aqp9

expression in response to hyperosmotic media. I then investigated whether hyperosmotic
media induced apoptosis at the blastocyst stage. 8-cell embryos were cultured for 6h in
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hyperosmotic media and then placed in normal osmotic media for 24h until they
developed into blastocysts. Apoptosis was assessed by TUNEL and Caspase 3 staining.
Embryos cultured in hyperosmotic media demonstrate increased levels of apoptosis
compared to control embryos. To determine if the MAPK pathways p38 or JNK/SAPK
contribute to the increased levels of apoptosis in response to hyperosmotic media, I
exposed embryos to hyperosmotic media in the presence of the p38 MAPK inhibitor or
the JNK/SAPK MAPK inhibitor. Apoptosis levels in response to hyperosmotic stress are
attenuated in embryos exposed to JNK/SAPK MAPK inhibitor but not in embryos that
were p38MAPK inhibited.
Conclusion 2.1

Aqp3 and Aqp9 expression is elevated in response to hyperosmotic
stress.

Conclusion 2.2

The p38 MAPK pathway, but not the JNK/SAPK MAPK pathway,
regulates Aqp3 and Aqp9 expression in response to hyperosmotic
stress.

Conclusion 2.3

Hyperosmotic stress causes increased levels of apoptosis at the
blastocyst stage.

Conclusion 2.4

The JNK/SAPK MAPK pathway, but not the p38 MAPK pathway,
regulates apoptosis in response to hyperosmotic stress.

It has already been demonstrated that p38 MAPK is required for preimplantation
development at the onset of compaction.

Thus, the objective of study two was to

determine if p38 MAPK is required at a later stage of preimplantation development—
blastocyst formation. I determined that inhibition of the p38 MAPK pathway at the early
blastocyst stage limits blastocyst expansion and prevents blastocyst hatching. Embryos
cultured in p38 MAPK inhibitor were less expanded after 12h and 24h and failed to
recover after the inhibitor was removed. P38 MAPK inhibited embryos also failed to
hatch. Embryos treated with the p38 MAPK inhibitor displayed normal localization of
CDX2 and CDH1.

p38 MAPK inhibited embryos have increased TJ permeability,
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disrupted localization of TJP1 after 12h and 24h of treatment and reduced Aqp3 mRNA
expression and AQP3 detection after 24h of treatment. P38 MAPK inhibited embryos
also display higher levels of apoptosis than controls.
Conclusion 3.1

The p38 MAPK pathway is required for embryo expansion and
hatching.

Conclusion 3.2

Inhibition of the p38 MAPK pathway results in increased TJ
permeability.

Conclusion 3.3

Inhibition of the p38 MAPK pathway results in aberrant cortical
distribution of TJP1.

Conclusion 3.4

Inhibition of the p38 MAPK pathway results in reduced Aqp3
mRNA expression and AQP3 detection after 24h of treatment.

Conclusion 3.5

Inhibition of the p38 MAPK pathway results in greater apoptosis
after 24h of treatment.

The objective of study three was to characterize the mRNA expression and protein
localization of one target of p38 MAPK, Snai1, and a related family member, Snai2,
throughout preimplantation development.

Quantitative RT-PCR and whole mount

immunofluorescence at each stage of preimplantation development (1-cell, 2-cell, 4-cell,
8-cell, morula and blastocyst) were applied to characterize Snai1 and Snai2 expression. I
demonstrated that Snai1 and Snai2 were present at each stage of embryo development
and that Snai1 expression is elevated at the 2-cell stage, potentially indicating a role for
Snai1 in MET. I also demonstrated that SNAI1 and SNAI2 localization is polarized in
the cytoplasm of individual blastomeres at the 2-cell, 4-cell and 8-cell stage, subsequently
becoming segregated to the outer cells of the morula, with variable expression in TE cells
at the blastocyst stage.
Conclusion 4.1

Snai1 and Snai2 are expressed throughout preimplantation
development.
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Conclusion 4.2

SNAI1 and SNAI2 are expressed throughout preimplantation
development and have a unique polarized distribution from the 2cell stage to the 8-cell stage.

Conclusion 4.3

SNAI1 and SNAI2 are expressed in the outer cells of the morula
and variable expression of SNAI1 and SNAI2 in the TE cells of the
blastocyst could indicate a role in TE differentiation.

I have therefore revised Figure 1.6 Proposed Model of MAPK regulation of TE
associated proteins in response to Stress and Development and have developed a new
model incorporating the conclusions outlined in this thesis (Figure 5.1).
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Figure 5.1 Revised Model of MAPK Regulation of TE Associated Proteins in
Response to Stress and Development (Figure 1.6)
This model is a revision of the prediction based on the literature. The JNK/SAPK
pathway regulates apoptosis in response to stress. The p38 MAPK pathway regulates
embryonic responses to culture stress through Aqp3 and Aqp9 expression but does not
regulate apoptosis (red ‘x’). The p38 MAPK pathway contributes to blastocyst formation
by regulating blastocyst expansion, hatching and TJs, but does not regulate CDX2
localization (red ‘x’). SNAI1 and SNAI2 are detectible in the TE, however their role in
the preimplantation embryo requires further investigation. Green arrows indicate
transcriptional regulation; purple arrows indicate activation; red bars indicate inhibition;
blue circles indicate nuclei.

174

Apical

Basolateral

175

5.2 SIGNIFICANCE OF RESEARCH
The MAPK pathways are involved in many cellular processes, including those involved
in housekeeping and stress response.

The MAPK pathways also play both a

developmental role and an adaptive role throughout embryonic development. My studies
have provided new knowledge on what the developmental role and the adaptive role of
the MAPK pathways are in the preimplantation embryo.
5.2.1 MAPK REGULATION OF BLASTOCYST ASSOCIATED PROTEINS
5.2.1.1 Aqp3 and Aqp9
Blastocyst expansion is dependent on several proteins working in concert to accumulate
fluid within the blastocyst cavity in preparation for implantation (Watson et al., 2004).
TJ, AJ, the Na/K ATPase and the AQPs each play an important role in fluid accumulation
within the blastocyst cavity (Watson et al., 2004). The AQPs, in particular, are present
and functional in the preimplantation embryo and facilitate the movement of fluid across
the TE (Barcroft et al., 2003; Offenberg et al., 2000). It was therefore important to
elucidate the mechanism by which Aqps are regulated in the preimplantation embryo.
My first and second study elucidated the role of p38 MAPK, in response to culture stress
and blastocyst expansion, in regulating Aqp3 and Aqp9. In my first study, I demonstrated
that Aqp3 and Aqp9 expression is elevated in response to hyperosmotic stress (Bell et al.,
2009). This is consistent with other studies that demonstrate an increase in Aqp
expression in the preimplantation embryo in response to hyperosmotic stress (Offenberg
& Thomsen, 2005). I then investigated how the elevated Aqp3 and Aqp9 expression was
regulated. Fong et al., 2007, had reported that the p38 MAPK pathway is active in
response to hyperosmotic stress; however the downstream targets of p38 MAPK were
still unknown. This led me to investigate p38 MAPK as a possible regulator of Aqp3 and
Aqp9. My results showed that, indeed, the elevated expression of Aqp3 and Aqp9 were
being regulated by the p38 MAPK pathway. These results are consistent with what has
previously been reported by Arima et al., 2003 regarding the regulation of Aqp
expression in response to hyperosmotic conditions. Using pharmacological inhibitors for
the conventional MAPK pathway, Arima et al., 2003 determined that the p38 MAPK
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pathway, but not the JNK/SAPK or ERK MAPK pathways, regulated Aqp expression in
response to hyperosmotic stress in cultured rat astrocytes (Arima et al., 2003). This is
also consistent with what we have reported regarding JNK/SAPK, that this pathway does
not regulate Aqp expression in response to hyperosmotic stress (Bell et al., 2009). The
ERK MAPK pathway has, however, been implicated in regulating Aqp expression in
response to hyperosmotic stress in a rat SV40 immortalized submandibular acinar cell
line and future studies investigating the role of the ERK pathway in cellular volume
regulation in response to hyper- or hyposmotic stress should be conducted (Hansen &
Galtung, 2007). In my second study, I investigated the p38 MAPK pathway during
blastocyst cavitation. I demonstrated that by inhibiting the p38 MAPK pathway, Aqp3
expression, but not Aqp9 expression, is significantly reduced. Taken together, these
results indicate that the p38 MAPK pathway regulates Aqp3 expression in response to
stress as well as during normal development. This also indicates that Aqp9 is differently
regulated than Aqp3 by the p38 MAPK pathway since it only regulated Aqp9 in response
to culture stress and not during blastocyst cavitation. These results have provided insight
into the role of the p38 MAPK pathway which does indeed regulate the expression of
Aqp3 in the blastocyst and contributes to blastocyst expansion as well as regulating the
embryonic response to stress.
5.2.1.2 Tight Junctions and Adherens Junctions
In study two, I showed that inhibition of p38 MAPK pathway signaling results in
compromised TJ permeability. The TJ seal surrounding the outer cells of the TE is
required to promote cavitation and maintain blastocyst expansion (Fleming et al., 1993;
Denker & Nigam, 1998; Kim et al., 2004; Moriwaki et al., 2007). At a significantly
higher frequency, p38 MAPK inhibited embryos allow 40 kDa molecules to pass through
the TJs into the blastocyst cavity compared with control embryos. This may be due to
aberrant localization of TJP1 along the cortical membrane. The p38 MAPK pathway
does regulate TJP1 in response to culture stress and this is mediated by the TF Snai1
(Strippoli et al., 2010). In study three, I have demonstrated that both SNAI1 and SNAI2
are present throughout preimplantation development and are segregated to the TE. It is
possible that the p38 MAPK pathway regulates proteins involved in blastocyst expansion

177
through the TFs localized to the TE, SNAI1 and SNAI2. These results, along with the
results from study one, indicate that the p38 MAPK pathway plays both an adaptive and
developmental role in regulating fluid accumulation in the blastocyst.
The p38 MAPK pathway is required for normal preimplantation development as
demonstrated by Natale et al., 2005 and Paliga et al., 2006. Inhibition of the p38 MAPK
pathway results in a reversible, developmental arrest at the 8-cell stage. This is primarily
contributed to by the loss of HSP and actin cytoskeleton (Paliga et al., 2005). Our studies
have revealed that p38 MAPK is also required at the blastocyst stage by regulating
blastocyst expansion and embryo hatching. p38 MAPK inhibited embryos have reduced
expansion compared with control embryos and do not hatch. These results compliment
knock-out studies that have indicated a role for p38-α during placentation. During
development, p38-α-/- embryos arrest at embryonic day 10.5 due to placental defects
(Adams et al., 2000).

Unlike the role p38 MAPK plays in regulating the actin

cytoskeleton at the 8-cell stage, inhibition of the p38 pathway at the blastocyst stage in
contrast did not affect the actin cytoskeleton (Natale et al., 2004; Paliga et al., 2005).
Rhodamine phalloidin staining of the actin cytoskeleton remained consistent between
control and p38 MAPK inhibited embryos. These results highlight the different roles that
the MAPK pathway plays during different stages of embryonic development.

This is

especially made clear in the role that the p38 MAPK pathway plays in regulating Cdh1
during gastrulation (Zohn et al., 2006). During gastrulation, p38 MAPK down-regulates
Cdh1 expression resulting in normal mesoderm migration (Zohn et al., 2006). Loss of
p38 MAPK signaling results in misexpression of Cdh1 leading to gastrulation defects
(Zohn et al., 2006). Inhibition of p38 MAPK during blastocyst formation, however, did
not affect Cdh1 localization.
In my first study, embryos were treated for 24h in the presence of the p38 MAPK
inhibitor SB 220025. However, embryos were treated from the 8-cell stage and allowed
to cavitate and progress to the blastocyst stage for 24h. Therefore, unlike my second
study, where embryos were treated at the blastocyst stage and allowed to cavitate for 24h,
embryos treated in my first study would not have yet been mature enough to hatch. I
therefore did not observe a hatching defect in embryos cultured in KSOMaa + SB 220025
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in my first study. This does reveal an important limitation of my studies. Using the
formation of a blastocyst as a metric for embryo health does not necessarily indicate
future embryo health, potential for implantation, ability to maintain a successful
pregnancy or produce healthy offspring at the time of birth or later into adulthood. These
results however do provide greater insight into the mechanisms available to the embryo in
responding to changes in culture stress and environment during blastocyst formation.
5.2.2 MAPK REGULATION OF APOPTOSIS
I have demonstrated that 8-cell embryos exposed for 6h to hyperosmotic stress display
increased levels of apoptosis at the blastocyst stage compared to controls.

This is

consistent with what has been reported by Xie et al. 2007, regarding embryos cultured in
hyperosmotic media at the blastocyst stage.

Xie et al. 2007, cultured embryos in

hyperosmotic KSOMaa media and demonstrated that the JNK/SAPK pathway was
activated in response to hyperosmotic media.

Furthermore, culture in hyperosmotic

media in the presence of the JNK/SAPK inhibitor prevented increased apoptosis (Xie et
al., 2007). Our studies also demonstrated that the JNK/SAPK MAPK pathway regulated
apoptosis in response to hyperosmotic stress in the preimplantation embryo. Embryos
cultured in the presence of hyperosmotic stress and JNK/SAPK inhibitor do not display
any apoptotic nuclei compared with embryos treated by hyperosmotic stress alone (Bell
et al., 2009). This is consistent with the role JNK/SAPK plays many different tissue types
in response to hyperosmotic stress (Chen et al., 2008; Xie et al., 2006; Xie et al., 2007;
Zhong et al., 2004).
Alternatively, the p38 MAPK pathway does not regulate apoptosis in response to
hyperosmotic stress. Embryos exposed to hyperosmotic stress in the presence of a p38
MAPK inhibitor displayed the same level of apoptosis as embryos cultured in
hyperosmotic medium alone (Bell et al., 2009). Xie et al., 2006 also reported that
embryos cultured in KSOMaa in the presence of a JNK/SAPK inhibitor developed faster
and demonstrated reduced apoptotic levels compared to control embryos cultured in
KSOMaa alone (Xie et al., 2006; Xie et al., 2007). However, our studies revealed that
the JNK/SAPK MAPK and the p38 MAPK pathway did not play a role in basal levels of
apoptosis at this stage of development. Embryos cultured in KSOMaa in the presence of
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the p38 MAPK or the JNK/SAPK inhibitor display the same levels of apoptosis as
embryos cultured in KSOMaa alone (Bell et al., 2009). Individual knock-out mice of
each member of the JNK/SAPK pathway are viable and demonstrate few deformities
(reviewed in Aouadi et al., 2006) . However, double knock-out mice of JNK1 and JNK2
are embryonic lethal and arrest at embryonic stage 11 due to malformation in the neural
tube and reduced apoptosis in the hind brain indicating a developmental regulation of
apoptosis by the JNK/SAPK MAPK pathway (reviewed in Aouadi et al., 2006). In study
two, we demonstrate that inhibition of the p38 MAPK pathway results in increased
apoptosis, where embryos cultured for 24h in the presence of a p38 inhibitor demonstrate
increased apoptosis compared to embryos cultured in KSOMaa or SB 202474 alone.
However, the interpretation of this result is that prolonged inhibition of p38 MAPK
activity results in a considerable stress response by the embryo that extends well beyond
the adaptive capacity of the embryo and therefore triggers apoptotic pathways. My
hypothesis is that the p38 MAPK pathway is not playing a role in regulating apoptosis
directly; however inhibiting the p38 MAPK pathway causes stress and apoptosis results.
This is consistent with our results from study one where p38 MAPK did not affect
apoptosis levels in hyperosmotic embryos (Bell et al., 2009).
These results highlight the important differences between the adaptive and developmental
roles that the MAPK pathways play throughout embryogenesis. Knock-out studies
demonstrate the developmental role that the MAPK play throughout gestation; however
they do not necessarily provide insight into the adaptive role these pathways play in
response to environmental factors. Further study into the adaptive roles of the MAPK
pathways throughout gestation is warranted.
My studies have therefore added to the growing body of knowledge investigating the
molecular mechanisms that regulate blastocyst formation.
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5.3 Future Studies
My studies have revealed a distinct role for the p38 MAPK pathway at the blastocyst
stage from the 8-16 cell stage of preimplantation development. These results reiterate
that the MAPK pathways play unique roles within specific tissues and at certain points
throughout development. A detailed analysis of the role of the ERK pathway and the
JNK/SAPK pathway should be undertaken at each cleavage stage of development and the
blastocyst stage.
Additionally, the protein localization of SNAI1 and SNAI2 is very exciting at each stage
of preimplantation development. Asymmetrical expression of a protein in the cytosol as
early as the 2-cell stage has not been previously reported and leads to many questions
such as: Why are these TFs being produced and sequestered to the cytoplasm? Do these
TFs retain their localization from the 2-cell stage throughout subsequent cleavages?
What could Snai1 and Snai2 be doing in the embryo? Do they play a role in TE
differentiation? These questions are important future directions to elucidate the
mechanisms the embryo utilizes to determine which blastomere will contribute to the TE
versus the ICM.

5.4 Summary
The preimplantation embryo represents the most vulnerable period of embryonic loss
throughout pregnancy.

It is therefore imperative that we elucidate the mechanisms

involved in regulated preimplantation embryonic response to stress and mechanisms that
govern development.

The MAPK pathways are involved in both responding to

environmental stress and regulating development throughout embryogenesis. Therefore
the MAPKs are good candidates to study in order to elucidate the mechanisms involved
in preimplantation embryonic adaptation to stress and development. I have demonstrated
that the p38 MAPK plays an integral role in the preimplantation embryo by regulating
blastocyst formation family genes in response to stress and during blastocyst cavitation. I
have also demonstrated that two TFs, Snai1 and Snai2, which are downstream targets of
the p38 MAPK pathway, are present throughout preimplantation development. SNAI1
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and SNAI2 also have a unique asymmetric distribution pattern from the 2-cell to 8-cell
stage, and are then segregated to the TE of the blastocyst. These results suggest that
SNAI1 and SNAI2 may be involved in TE differentiation or regulation. Taken together,
these results have further elucidated the role for the p38 MAPK pathway in the
preimplantation embryo and have revealed an exciting new set of TFs that are associated
with the TE.
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APPENDIX A

Supplemental Figures From:
P38 MAPK Regulates Cavitation and Tight Junction Function in the Mouse
Blastocyst
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Supplemental Figure 1: Method of Measuring Blastocyst Expansion
Embryo diameters were measured for dose response and recovery experiments. Embryos
were measured in two different directions and then the measurement was averaged.
Volume was then calculated based on the calculated radius.
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Supplemental Figure 2: Timeline of Experiments
Timeline for embryo collection, treatment time, and recovery time for all experiments.
Embryos were collected at 89h post hCG and cultured for 12h or 24h. Embryos were
imaged and measured at 0h, 4h, 8h, 12h, and 24h post hCG, and again following
recovery, at 24h, 28h and 36h post hCG. Embryos were collected at 12h or 24h and
either analyzed for RT-PCR, FITC assay, TUNEL assay or immunofluorescence or
placed into fresh culture drops and allowed to recover. Hatching was assessed at 24h
post hCG.
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Supplemental Figure 3: Representative Images of Blastocyst Expansion
Representative images of embryos from each treatment group at each time point during
the concentration response experiment. Scale bar = 20 microns.
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Supplemental Figure 4: Representative Images of Blastocyst Expansion During
Recovery
Representative images of embryos from each treatment group at each time point during
the recovery experiment. Scale bar = 20 microns.
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Supplemental Figure 5: Embryo Expansion After SB203580 Treatment
Embryos were cultured for 24 h in control media (KSOMaa and SB 202474) or in
KSOMaa + SB 203580 and imaged at 0 h, 12 h, and 24 h of treatment. The diameter of
each embryo was measured as described in Supplemental Figure 1 and volume was
calculated from the radius. After 24 h embryos cultured in SB 203580 were significantly
less expanded than controls. Three replicates were performed and 15-20 embryos were
measured in each group. SEM; p≤0.05.
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Supplemental Figure 6: ERK and Phospho ERK Expression in p38 MAPK
Inhibited Embryos
Total-ERK and phospho–ERK protein following treatment with KSOMaa, SB 202474, or
SB 220025 using immunofluorescence. Representative images of total-ERK after 24 h of
treatment KSOMaa (A), SB 202474 (B) or SB 220025 (C) and phospho-ERK after 24 h
of treatment KSOMaa (D), SB 202474 (E) or SB 220025 (F). There was no visible
difference between total-ERK or phospho-ERK between the treatment groups. Green =
total-ERK (A-C); Green = phosphor-ERK (D-F); No primary (G) n=10-15 embryos in
each group; scale bar = 10 microns.
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Supplemental Figure 7: Quantitative RT-PCR Primer Sets

Real-time primer sets
Ocludin 5'

AAATTAGCTCATACTCGTTGATAG

Ocludin 3'

CAAGAATATGTACTGCCATGTC

ZO-1 5'

AGATCCTGAGCCGGTGTCTG

ZO-1 3'

TCCTCTCCCTGCTTGCACTC

Atp1b1 5'

GCCTACGTGCTAAACATCATCAG

Atp1b1 3'

GATTGATGTCGCCCCGTTCC

Gapdh 5'

CAACGACCCCTTCATTGACCT

Gapdh 3'

ATCCACGACCGACACATTGG
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APPENDIX B

Supplemental Figures from:
SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become
Segregated to the TE in the Mouse Blastocyst
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Supplemental Figure 1: Antisera Validation in Preimplantation Embryos
Antisera validation in preimplantation embryos. (A and B) Antibody pre-absorption
assays revealed the specificity of the SNAI1 (A) and SNAI2 (B) antisera. Embryos
incubated in antisera pre-absorbed with SNAI1 or SNAI2 peptide displayed comparable
levels of SNAI1 or SNAI2 expression with negative controls. (C and D) Negative siRNA
or siRNA targeting Snai1 or Snai2 was microinjected into 1-cell embryos. Whole-mount
immunofluorescence was applied detecting SNAI1 (C) and SNAI2 (D) in control and
knock-down embryos. SNAI1 (C) and SNAI2 (D) expression was significantly down
regulated in the embryos that were microinjected with siRNA targeted to Snai1 or Snai2.
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Supplemental Figure 2: Antisera Validation in NIH 3T3 cells
Antisera validation in NIH3T3 cells. (A and B) SNAI1 and SNAI2 antibodies were used
to detect SNAI1 (A) and SNAI2 (B) in NIH3T3 cells (C- no primary control). This
experiment revealed that these antisera replicated the published localization pattern of
SNAI1 and SNAI2 in NIH3T3 cells. (D) Western Blot analysis was performed to
determine the specificity of the antisera. Single protein bands for both SNAI1 and SNAI2
were detected at the expected molecular weight for each protein. Protein bands were no
longer detected when membranes were incubated in pre-absorbed SNAI1 and SNAI2
antisera. Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 or SNAI2. Scale bars
= 10 microns.
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Supplemental figure 4:
Diagrammatic representation of SNAI1 localization throughout preimplantation
development.
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Supplemental figure 5:
Diagrammatic representation of SNAI2 localization throughout preimplantation
development.
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